Publikationen & Awards

Interdisciplinary Model for Scheduling Post-discharge Cardiopulmonary Care of Patients Following Severe and Critical SARS-CoV-2 (Coronavirus) Infection.
Kopp, K; Lichtenauer, M; Motloch, LJ; Hoppe, UC; Egle, A; Salzer, HJF; Lamprecht, B; Tomasits, J; Müller, HM; Dieplinger, A;

View this publication in the PUBMED database

Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L;

View this publication in the PUBMED database

CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr, JC; Bayer, E; Yu, X; Laufer, JM; Höpner, JP; Tesanovic, S; Härzschel, A; Auer, G; Rieß, T; Salmhofer, A; Szenes, E; Haslauer, T; Durand-Onayli, V; Ramspacher, A; Pennisi, SP; Artinger, M; Zaborsky, N; Chigaev, A; Aberger, F; Neureiter, D; Pleyer, L; Legler, DF; Orian-Rousseau, V; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe.
Berzow, D; Descamps, D; Obermeier, M; Charpentier, C; Kaiser, R; Guertler, L; Eberle, J; Wensing, A; Sierra, S; Ruelle, J; Gomes, P; Mansinho, K; Taylor, N; Jensen, B; Döring, M; Stürmer, M; Rockstroh, J; Camacho, R;

View this publication in the PUBMED database

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; St?ger, H; Stotz, M; Gerger, A; Pichler, M

View this publication in the PUBMED database

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
Gassner, FJ; Zaborsky, N; Buchumenski, I; Levanon, EY; Gatterbauer, M; Schubert, M; Rauscher, S; Hebenstreit, D; Nadeu, F; Campo, E; Egle, A; Greil, R; Geisberger, R

View this publication in the PUBMED database

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M

View this publication in the PUBMED database

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stoger, H; Stotz, M; Gerger, A; Pichler, M

View this publication in the PUBMED database

Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population.
Ludwig, H; Ponisch, W; Knop, S; Egle, A; Hinke, A; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Petzer, A; Weisel, K; Niederwieser, D; Einsele, H; Willenbacher, W; Rumpold, H; Pour, L; Jelinek, T; Krenosz, KJ; Meckl, A; Nolte, S; Melchardt, T; Greil, R; Zojer, N

View this publication in the PUBMED database

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Papakonstantinou, A; Hedayati, E; Hellstrom, M; Johansson, H; Gnant, M; Steger, G; Greil, R; Untch, M; Moebus, V; Loibl, S; Foukakis, T; Bergh, J; Matikas, A

View this publication in the PUBMED database

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Wagner, SM; Melchardt, T; Egle, A; Magnes, T; Skrabs, C; Staber, P; Simonitsch-Klupp, I; Panny, M; Lehner, B; Greil, R; Keil, F; Jäger, U; Sillaber, C;

View this publication in the PUBMED database

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.
Hufnagl, C; Leisch, M; Weiss, L; Melchardt, T; Moik, M; Asslaber, D; Roland, G; Steininger, P; Meissnitzer, T; Neureiter, D; Greil, R; Egle, A;

View this publication in the PUBMED database

Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance.
Park, E; Chen, J; Moore, A; Mangolini, M; Santoro, A; Boyd, JR; Schjerven, H; Ecker, V; Buchner, M; Williamson, JC; Lehner, PJ; Gasparoli, L; Williams, O; Bloehdorn, J; Stilgenbauer, S; Leitges, M; Egle, A; Schmidt-Supprian, M; Frietze, S; Ringshausen, I;

View this publication in the PUBMED database

Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis.
Haslbauer, F; Petzer, A; Safanda, M; Tomova, A; Porubska, M; Bajory, Z; Niepel, D; Jaeger, C; Bjorklof, K; Kalinin, D; Greil, R;

View this publication in the PUBMED database

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Murthy, RK; Loi, S; Okines, A; Paplomata, E; Hamilton, E; Hurvitz, SA; Lin, NU; Borges, V; Abramson, V; Anders, C; Bedard, PL; Oliveira, M; Jakobsen, E; Bachelot, T; Shachar, SS; Müller, V; Braga, S; Duhoux, FP; Greil, R; Cameron, D; Carey, LA; Curigliano, G; Gelmon, K; Hortobagyi, G; Krop, I; Loibl, S; Pegram, M; Slamon, D; Palanca-Wessels, MC; Walker, L; Feng, W; Winer, EP;

View this publication in the PUBMED database

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia.
Szenes, E; Harzschel, A; Decker, S; Tissino, E; Pischeli, J; Gutjahr, JC; Kissel, S; Pennisi, S; Hopner, JP; Egle, A; Zaborsky, N; Dierks, C; Follo, M; Chigaev, A; Zucchetto, A; Greil, R; Gattei, V; Hartmann, TN

View this publication in the PUBMED database

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network
Greinix, HT; Attarbaschi, A; Girschikofsky, M; Greil, R; Holter, W; Neumeister, P; Peters, C; Petzer, A; Rudzki, J; Schlenke, P; Schmitt, CA; Schwinger, W; Wolf, D; Worel, N; Jaeger, U

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Moehler, M; Maderer, A; Thuss-Patience, PC; Brenner, B; Meiler, J; Ettrich, TJ; Hofheinz, RD; Al-Batran, SE; Vogel, A; Mueller, L; Lutz, MP; Lordick, F; Alsina, M; Borchert, K; Greil, R; Eisterer, W; Schad, A; Slotta-Huspenina, J; Van Cutsem, E; Lorenzen, S

View this publication in the PUBMED database

"I was seen by a radiologist, but unfortunately I can"t remember the name and I still have questions. What should I do?" Radiologists should give thoughts to improve service professionalism and patient esteem.
Gutzeit, A; Fischmann, A; Forstner, R; Goette, R; Herzog, B; Kurtz, C; Hebler, C; Ladinger, A; Froehlich, JM; Blautzik, J; Kolokythas, O; Matoori, S; Kos, S; Reischauer, C; Schefer, H; Dubsky, P; Gampenrieder, SP; Hergan, K; Gaissmaier, W; Koh, DM; Meissnitzer, M

View this publication in the PUBMED database

Gemtuzumab Ozogamicin in
Schlenk, RF; Paschka, P; Krzykalla, J; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Leis, C; Fiedler, W; Kindler, T; Schroeder, T; Mayer, K; Lübbert, M; Wattad, M; Götze, K; Horst, HA; Koller, E; Wulf, G; Schleicher, J; Bentz, M; Greil, R; Hertenstein, B; Krauter, J; Martens, U; Nachbaur, D; Abu Samra, M; Girschikofsky, M; Basara, N; Benner, A; Thol, F; Heuser, M; Ganser, A; Döhner, K; Döhner, H;

View this publication in the PUBMED database

Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Rohner, E; Bütikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Taghavi, K; Moore, RD; Goedert, JJ; Gill, MJ; Silverberg, MJ; DSouza, G; Patel, P; Castilho, JL; Ross, J; Sohn, A; Bani-Sadr, F; Taylor, N; Paparizos, V; Bonnet, F; Verbon, A; Vehreschild, JJ; Post, FA; Sabin, C; Mocroft, A; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Quiros-Roldan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Barger, D; Clifford, GM; Franceschi, S; Egger, M; Bohlius, J;

View this publication in the PUBMED database

Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz, C; Romagna, A; Stefanits, H; Zimmermann, G; Ladisich, B; Geiger, P; Rechberger, J; Winkler, S; Weiss, L; Fastner, G; Trinka, E; Weis, S; Spiegl-Kreinecker, S; Steinbacher, J; McCoy, M; Johannes, T; Gruber, A; Jahromi, BR; Niemelä, M; Winkler, PA; Thon, N;

View this publication in the PUBMED database

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

A cross-trial comparison of single-agent ibrutinib
Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; Stevens, D; Gill, D; Flinn, IW; Kipps, TJ; Burger, JA; Lin, J; Webb, T; Fedorov, V; Styles, L; Gribben, JG;

View this publication in the PUBMED database

Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M;

View this publication in the PUBMED database

Structure-Guided Identification of Black Cohosh (
Johrer, K; Stuppner, H; Greil, R; Cicek, SS

View this publication in the PUBMED database

Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera.
Wagner, SM; Melchardt, T; Greil, R;

View this publication in the PUBMED database

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:
Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Woll, E; Gerger, A

View this publication in the PUBMED database

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
Huemer, F; Weiss, L; Regitnig, P; Winder, T; Hartmann, B; Thaler, J; Piringer, G; Schmitt, CA; Eisterer, W; Gänzer, H; Wüstner, A; Andel, J; Jagdt, B; Ulmer, H; Greil, R; Wöll, E;

View this publication in the PUBMED database

Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
Papakonstantinou, A; Matikas, A; Bengtsson, NO; Malmstrom, P; Hedayati, E; Steger, G; Untch, M; Hubbert, L; Johansson, H; Hellstrom, M; Gnant, M; Loibl, S; Greil, R; Moebus, V; Foukakis, T; Bergh, J

View this publication in the PUBMED database

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L;

View this publication in the PUBMED database

Correction to: The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Bjelic-Radisic, V; Fitzal, F; Knauer, M; Steger, G; Egle, D; Greil, R; Schrenk, P; Balic, M; Singer, C; Exner, R; Soelkner, L; Gnant, M

View this publication in the PUBMED database

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Wulf, GG; Altmann, B; Ziepert, M; DxxxAmore, F; Held, G; Greil, R; Tournilhac, O; Relander, T; Viardot, A; Wilhelm, M; Wilhelm, C; Pezzutto, A; Zijlstra, JM; Van Den Neste, E; Lugtenburg, PJ; Doorduijn, JK; van Gelder, M; van Imhoff, GW; Zettl, F; Braulke, F; Nickelsen, M; Glass, B; Rosenwald, A; Gaulard, P; Loeffler, M; Pfreundschuh, M; Schmitz, N; Trumper, L

View this publication in the PUBMED database

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Huemer, F; Leisch, M; Geisberger, R; Melchardt, T; Rinnerthaler, G; Zaborsky, N; Greil, R;

View this publication in the PUBMED database

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Paar, V; Wernly, B; Zhou, Z; Motloch, LJ; Hoppe, UC; Egle, A; Lichtenauer, M;

View this publication in the PUBMED database

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M

View this publication in the PUBMED database

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.
Barraco, F; Greil, R; Herbrecht, R; Schmidt, B; Reiter, A; Willenbacher, W; Raymakers, R; Liersch, R; Wroclawska, M; Pack, R; Burock, K; Karumanchi, D; Gisslinger, H

View this publication in the PUBMED database

Dysphagia in the Context of a Serious Systemic Disease.
Ferstl, FS; Gampenrieder, SP; Renneberg, F; Roesch, S;

View this publication in the PUBMED database

Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke, S; Ortner, D; Szenes-Nagy, AB; Zaborsky, N; Weiss, R; Neureiter, D; Wipplinger, M; Risch, A; Hammerl, P; Greil, R; Sibilia, M; Gratz, IK; Stoitzner, P; Aberger, F;

View this publication in the PUBMED database

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.
Rinnerthaler, G; Gampenrieder, SP; Hackl, H; Steiner, M; Monzo-Fuentes, C; Melchardt, T; Magnes, T; Huemer, F; Westphal, T; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R;

View this publication in the PUBMED database

Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
Schaffler-Schaden, D; Sassmann, R; Johansson, T; Gampenrieder, SP; Rinnerthaler, G; Lampl, K; Herfert, J; Lenzhofer, C; Landkammer, YT; Rieder, F; Greil, R; Flamm, M; Niebauer, J;

View this publication in the PUBMED database

RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.
Gassner, FJ; Zaborsky, N; Feldbacher, D; Greil, R; Geisberger, R

View this publication in the PUBMED database

Prognosis of triple negative metastatic breast cancer (MBC): Results from the AGMT_MBC-Registry
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)
Murthy, R; Loi, S; Okines, A; Paplomata, E; Hamilton, E; Hurvitz, S; Lin, N; Borges, V; Abramson, VG; Anders, C; Bedard, PL; Oliveira, M; Jakobsen, E; Bachelot, T; Shachar, SS; Mueller, V; Braga, S; Duhoux, FP; Greil, R; Cameron, D; Carey, L; Curigliano, G; Gelmon, K; Hortobagyi, G; Krop, I; Loibl, S; Pegram, M; Slamon, D; Palanca-Wessels, MC; Walker, L; Feng, WT; Winer, E

Landscape of HER2-low metastatic breast cancer (MBC): Results from the AGMT-MBC-Registry
Gampenrieder, SP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

Randomized Phase III Study of FOLFOX Alone and with Pegilodecakin as Second-line Therapy in Patients with Metastatic Pancreatic Cancer (SEQUOIA)
Hecht, JR; Lonardi, S; Bendell, JC; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Lin, Y; Rao, S; Ryoo, BY

Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217
Folprecht, G; Reinacher-Schick, A; Tannapfel, A; Weitz, J; Kossler, T; Weiss, L; Aust, DE; von Bubnoff, N; Kramer, M; Thiede, C

TRYbeCA-1: A randomized, phase III study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Noel, MS; Seufferlein, T; Creemers, GY; Gupta, A; Salesse, S; Biswas-Baldwin, N; Dion, H; Youssoufian, H; Garzon, FT; El-Hariry, I; Hidalgo, M

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Gianni, L; Huang, CS; Egle, D; Bermejo, B; Zamagni, C; Thill, M; Anton, A; Zambelli, S; Bianchini, G; Russo, S; Ciruelos, E; Greil, R; Semiglazov, V; Colleoni, M; Kelly, C; Mariani, G; Del Mastro, L; Maffeis, I; Valagussa, P; Viale, G

Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy targeting prostate-specific membrane antigen (PSMA), in patients with metastatic castration-resistant prostate cancer (mCRPC)
Tran, B; Horvath, L; Dorff, TB; Greil, R; Machiels, JPH; Roncolato, F; Autio, KA; Rettig, M; Fizazi, K; Lolkema, MP; Fermin, AC; Salvati, M; Kouros-Mehr, H

REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC)
Singer, CF; Egle, D; Greil, R; Ohler, L; Petru, E; Suppan, C; Marhold, M; Pfeiler, G; Brunner, C; Tinchon, C; Halper, S; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Hennebelle, M; Mraz, B; Bartsch, R

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
Leisch, M; Greil, R; Pleyer, L

View this publication in the PUBMED database

Noch keine Publikation im Jahr 2020 vorhanden

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
Valent, P; Orazi, A; Savona, MR; Patnaik, MM; Onida, F; van de Loosdrecht, AA; Haase, D; Haferlach, T; Elena, C; Pleyer, L; Kern, W; Pemovska, T; Vladimer, GI; Schanz, J; Keller, A; Lubbert, M; Lion, T; Sotlar, K; Reiter, A; De Witte, T; Pfeilstocker, M; Geissler, K; Padron, E; Deininger, M; Orfao, A; Horny, HP; Greenberg, PL; Arber, DA; Malcovati, L; Bennett, JM

View this publication in the PUBMED database

Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry.
Rejto, J; Reitter-Pfoertner, S; Kepa, S; Feistritzer, C; Grundbichler, M; Horbst, A; Jones, N; Muntean, W; Neumeister, P; Oberbichler, S; Schuster, G; Schwarz, R; Thom, K; Zwiauer, K; Streif, W; Male, C; Pabinger, I

View this publication in the PUBMED database

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber, D; Wacht, N; Leisch, M; Qi, Y; Maeding, N; Hufnagl, C; Jansko, B; Zaborsky, N; Villunger, A; Hartmann, TN; Greil, R; Egle, A;

View this publication in the PUBMED database

Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
Ludwig, H; Poenisch, W; Knop, S; Egle, A; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Krenosz, KJ; Petzer, A; Weisel, K; Niederwieser, D; Einsele, H; Willenbacher, W; Melchardt, T; Greil, R; Zojer, N

View this publication in the PUBMED database

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B;

View this publication in the PUBMED database

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia
Willenbacher, E; Johrer, K; Willenbacher, W; Flogel, B; Greil, R; Kircher, B

View this publication in the PUBMED database

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Leisch, M; Jansko, B; Zaborsky, N; Greil, R; Pleyer, L

View this publication in the PUBMED database

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF

View this publication in the PUBMED database

Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
Bolger, GT; Licollari, A; Bagshaw, R; Tan, AM; Greil, R; Vcelar, B; Majeed, M; Sordillo, P

View this publication in the PUBMED database

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno, C; Greil, R; Demirkan, F; Tedeschi, A; Anz, B; Larratt, L; Simkovic, M; Samoilova, O; Novak, J; Ben-Yehuda, D; Strugov, V; Gill, D; Gribben, JG; Hsu, E; Lih, CJ; Zhou, C; Clow, F; James, DF; Styles, L; Flinn, IW;

View this publication in the PUBMED database

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;

View this publication in the PUBMED database

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Rucker, FG; Agrawal, M; Corbacioglu, A; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Jahn, N; Schroeder, T; Wattad, M; Lubbert, M; Koller, E; Kindler, T; Gotze, K; Ringhoffer, M; Westermann, J; Fiedler, W; Horst, HA; Greil, R; Schroers, R; Mayer, K; Heinicke, T; Krauter, J; Schlenk, RF; Thol, F; Heuser, M; Ganser, A; Bullinger, L; Paschka, P; Dohner, H; Dohner, K

View this publication in the PUBMED database

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Burtness, B; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Baste, N; Neupane, P; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Hong, RL; Mendoza, RG; Roy, A; Zhang, YY; Gumuscu, B; Cheng, JD; Jin, F; Rischin, D

View this publication in the PUBMED database

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study
Thieblemont, C; Howlett, S; Casasnovas, RO; Mounier, N; Perrot, A; Morschhauser, F; Fruchart, C; Daguindau, N; van Eygen, K; Oberic, L; Bouabdallah, R; Pica, GM; Nicolas-Virezelier, E; Abraham, J; Fitoussi, O; Snauwaert, S; Eisenmann, JC; Lionne-Huyghe, P; Bron, D; Tricot, S; Deeren, D; Gonzalez, H; Costello, R; Le Du, K; da Silva, MG; Grosicki, S; Trotman, J; Catalano, J; Caballero, D; Greil, R; Cohen, AM; Gaulard, P; Roulin, L; Takeshita, K; Casadebaig, ML; Tilly, H; Coiffier, B

View this publication in the PUBMED database

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A

View this publication in the PUBMED database

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A;

View this publication in the PUBMED database

Systemic treatment of metastatic breast cancer: SABCS 2018
Westphal, T; Gampenrieder, SP; Greil, R

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Fuchs, M; Goergen, H; Kobe, C; Kuhnert, G; Lohri, A; Greil, R; Sasse, S; Topp, MS; Schafer, E; Hertenstein, B; Soekler, M; Vogelhuber, M; Zijlstra, JM; Keller, UB; Krause, SW; Wilhelm, M; Maschmeyer, G; Thiemer, J; Duhrsen, U; Meissner, J; Viardot, A; Eich, H; Baues, C; Diehl, V; Rosenwald, A; von Tresckow, B; Dietlein, M; Borchmann, P; Engert, A

View this publication in the PUBMED database

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T

View this publication in the PUBMED database

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae).
Shulha, O; Cicek, SS; Wangensteen, H; Kroes, J; Mader, M; Girreser, U; Sendker, J; Johrer, K; Greil, R; Schuhly, W; Mangoni, A; Grauso, L; van Thriel, C; Zidorn, C

View this publication in the PUBMED database

Good Response of Lupus Hepatitis to Mycophenolate Mofetil and Belimumab as of Lupus Exanthema to Rituximab: A Case Report
Psenak, O; Studnicka-Benke, A; Haufe, H; Greil, R;

Mouse models to decipher anti-tumor immunity.
Parigger, T; Greil, R; Zaborsky, N;

View this publication in the PUBMED database

Anal Ureaplasma spp. positivity among HIV positive men who have sex with men may be associated with high-risk-type HPV infections.
Borena, W; Kruis, S; Kitchen, M; Taylor, N; Gisinger, M; Oberkofler, H; Stoiber, H; Zangerle, R; von Laer, D; Sarcletti, M

View this publication in the PUBMED database

Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.
Rivera, FJ; de la Fuente, AG; Zhao, C; Silva, ME; Gonzalez, GA; Wodnar, R; Feichtner, M; Lange, S; Errea, O; Priglinger, E; OSullivan, A; Romanelli, P; Jadasz, JJ; Brachtl, G; Greil, R; Tempfer, H; Traweger, A; Bátiz, LF; Küry, P; Couillard-Despres, S; Franklin, RJM; Aigner, L;

View this publication in the PUBMED database

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A; Melchardt, T; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Voskova, D; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R;

View this publication in the PUBMED database

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Woll, E; Eisterer, W; Gerger, A; Kuhr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R

View this publication in the PUBMED database

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Spicka, I; Ocio, EM; Oakervee, HE; Greil, R; Banh, RH; Huang, SY; DxxxRozario, JM; Dimopoulos, MA; Martinez, S; Extremera, S; Kahatt, C; Alfaro, V; Carella, AM; Meuleman, N; Hajek, R; Symeonidis, A; Min, CK; Cannell, P; Ludwig, H; Sonneveld, P; Mateos, MV

View this publication in the PUBMED database

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Scheithauer, W; Putora, PM; Grunberger, B; Eisterer, W; Woll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M

View this publication in the PUBMED database

Immunosuppressives and biologics during pregnancy and lactation: Aconsensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
Puchner, A; Groochenig, HP; Sautner, J; Helmy-Bader, Y; Juch, H; Reinisch, S; Hogenauer, C; Koch, R; Hermann, J; Studnicka-Benke, A; Weger, W; Puchner, R; Dejaco, C

View this publication in the PUBMED database

Hunting Poses Only a Low Risk for Alveolar Echinococcosis
Wetscher, M; Hacklander, K; Faber, V; Taylor, N; Auer, H; Duscher, GG

View this publication in the PUBMED database

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with
Schlenk, RF; Weber, D; Fiedler, W; Salih, HR; Wulf, G; Salwender, H; Schroeder, T; Kindler, T; Lübbert, M; Wolf, D; Westermann, J; Kraemer, D; Götze, KS; Horst, HA; Krauter, J; Girschikofsky, M; Ringhoffer, M; Südhoff, T; Held, G; Derigs, HG; Schroers, R; Greil, R; Grießhammer, M; Lange, E; Burchardt, A; Martens, U; Hertenstein, B; Marretta, L; Heuser, M; Thol, F; Gaidzik, VI; Herr, W; Krzykalla, J; Benner, A; Döhner, K; Ganser, A; Paschka, P; Döhner, H;

View this publication in the PUBMED database

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Majeed, M; Sordillo, PP;

View this publication in the PUBMED database

Cytotoxic Properties of Damiana (
Willer, J; Johrer, K; Greil, R; Zidorn, C; Cicek, SS

View this publication in the PUBMED database

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics.
Huemer, F; Rinnerthaler, G; Lang, D; Hackl, H; Lamprecht, B; Greil, R;

View this publication in the PUBMED database

Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M;

View this publication in the PUBMED database

Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi, F; Stättner, S; Schlick, K; Kiesslich, T; Mayr, C; Klieser, E; Urbas, R; Neureiter, D;

View this publication in the PUBMED database

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;

View this publication in the PUBMED database

Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.
Huemer, F; Schlintl, V; Hecht, S; Hackl, H; Melchardt, T; Rinnerthaler, G; Greil, R; Weiss, L;

View this publication in the PUBMED database

Obituary for Professor Michael Steurer
Egle, A;

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M

View this publication in the PUBMED database

Prediction of Distant Recurrence Using EndoPredict Among Women with ER
Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M;

View this publication in the PUBMED database

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.
Mirna, M; Lichtenauer, M; Theurl, T; Ausserwinkler, M; Topf, A; Westphal, T; Gampenrieder, SP; Pretsch, I; Greil, R; Hoppe, UC;

View this publication in the PUBMED database

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
Zaborsky, N; Gassner, FJ; Höpner, JP; Schubert, M; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Egle, A;

View this publication in the PUBMED database

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
Huemer, F; Lang, D; Westphal, T; Gampenrieder, SP; Hutarew, G; Weiss, L; Hackl, H; Lamprecht, B; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Fitzal, F; Bjelic-Radisic, V; Knauer, M; Steger, G; Hubalek, M; Balic, M; Singer, C; Bartsch, R; Schrenk, P; Soelkner, L; Greil, R; Gnant, M

View this publication in the PUBMED database

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A; Foukakis, T; Moebus, V; Greil, R; Bengtsson, NO; Steger, GG; Untch, M; Johansson, H; Hellström, M; Malmström, P; Gnant, M; Loibl, S; Bergh, J;

View this publication in the PUBMED database

Carcinoid heart disease involving the left heart: a case report and biomarker analysis.
Lichtenauer, M; Pichler, T; Eder, S; Mirna, M; Magnes, T; Wernly, B; Paar, V; Jung, C; Prinz, E; Seitelberger, R; Hoppe, UC;

View this publication in the PUBMED database

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.
Rinnerthaler, G; Gampenrieder, SP; Greil, R;

View this publication in the PUBMED database

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M;

View this publication in the PUBMED database

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Riedmann, M; Meissnitzer, T; Egger, H; Klaassen Federspiel, F; Reitsamer, R; Hauser-Kronberger, C; Stering, K; Hergan, K; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Fallbericht mit Baricitinib
Psenak, O;

FLIESSENDE SCHMERZEN BESSER BEHANDELN
Psenak, O;

Muskuloskelettale Pathophysiologie
Psenak, O;

Steife BWS und Schmerzen ISG: Normalbefund oder Morbus Bechterew? - Differenzialdiagnostik und neue Behandlungsmöglichkeiten für ein unterschätztes Krankheitsbild
Psenak, O;

Kasuistik: Skleritis und Vaskulitis
Psenak, O;

JAK-Inhibitoren: Fallberichte
Psenak, O;

Morbus Bechterew
Psenak, O;

Differentialdiagnose der Gelenksschwellungen
Psenak, O;

Psoriasis Arthritis
Psenak, O;

REACHAUT: First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) in the real-world setting.
Singer, CF; Oehler, L; Egle, D; Greil, R; Petru, E; Balic, M; Marhold, M; Pfeiler, G; Brunner, C; Kwasny, W; Galid, AA; Tinchon, C; Eisterer, W; Haslbauer, F; Hubalek, M; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Steger, GG

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

Tailored dose-dense chemotherapy in combination with trastuzumab as adjuvant therapy for HER2-positive breast cancer: A secondary analysis of the phase III PANTHER trial.
Foukakis, T; Papakonstantinou, A; Matikas, A; Bengtsson, NO; Malmstrom, P; Hedayati, E; Steger, GG; Untch, M; Hubbert, L; Johansson, H; Hellstrom, M; Gnant, M; Loibl, S; Greil, R; Moebus, V; Bergh, JCS

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Rischin, D; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; de Castro, G; Psyrri, A; Baste, N; Neupane, PC; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Zhang, YY; Jin, F; Gumuscu, B; Burtness, B

Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).
Hammel, P; Berardi, R; Van Cutsem, E; Feliu, J; Greil, R; Wasan, HS; Metges, JP; Nygren, P; Osterlund, PJ; Parner, V; Seufferlein, T; Gupta, A; Salesse, S; Biswasbaldwin, N; Ibrahim, A; Youssoufian, H; El-Hariry, I; Hidalgo, M

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, CC; Kasper, S; Hegewisch-Becker, S; Schroeder, J; Overkamp, F; Kullmann, F; Bechstein, WO; Vohringer, M; Oellinger, R; Lordick, F; Heinemann, V; Geissler, M; Schulz-Abelius, A; Linz, B; Bernhard, H; Schoen, MR; Greil, R; Smith-Machnow, V; Schmidtmann, I; Moehler, MH

Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
Wainberg, ZA; Lassen, UN; Elez, E; Italiano, A; Curigliano, G; De Braud, FG; Prager, G; Greil, R; Stein, A; Fasolo, A; Schellens, JHM; Wen, PY; Boran, AD; Burgess, P; Gasal, E; Ilankumaran, P; Subbiah, V

Impact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
Gampenrieder, SPP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R

Therapy line and associated predictors of response to PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC - a retrospective bi-centric cohort study
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B

POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017
Bohm, A; Lindner, B; Rabitsch, W; Kalhs, P; Worel, N; Clausen, J; Nachbaur, D; Neumeister, P; Panny, M; Keil, F; Russ, G; Eder, S; Isak, E; Zojer, N; Burger, S; Greinix, H

The melastatin-like Transient-Receptor-Potential-7 protein regulates Cyclooxygenase-2 expression in human myeloid leukemia cells
Hampe, S; Nadolni, W; Holting, K; Fraticelli, M; Addington, L; Steinritz, D; Chubanov, V; Boekhoff, I; Breit, A; Greil, R; Gudermann, T; Zierler, S

Impact of menopause status on breast cancer outcomes and amenorrhea incidence during adjuvant tailored dose dense chemotherapy
Papakonstantinou, A; Matikas, A; Hellstrom, M; Johansson, H; Steger, G; Greil, R; Loibl, S; Gnant, M; Moebus, V; Untch, M; Foukakis, T; Bergh, J

Antihormonal treatment with or without whole breast irradiation in low risk breast cancer patients after breast conserving surgery: 10-year results of the ABCSG 8A trial
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Gnant, M

The hepatitis C continuum of care among HIV-infected individuals in Austria
Rappold, M; Gisinger, M; Chromy, D; Schmied, B; Ollinger, A; Wallner, E; Zoufaly, A; Egle, A; Kanatschnig, M; Zangerle, R

BELINDA : A phase 3 study evaluating the safety and efficacy of tisagenlecleucel versus standard of care in adult patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Bishop, M; Flinn, I; Borchmann, P; Jaeger, U; Westin, J; Hamad, N; Purtill, D; Greil, R; Thomas, S; Teshima, T; Harigae, H; Garcia, C; Barba, P; Deol, A; Shaughnessy, P; Gu, J; Andreola, G; Prieto, MM; Pacaud, L; Schuster, S

Similar but different: Using combined phylogenies of Austria and Switzerland reveals differences in transmission patterns of the local HIV-1 epidemics
Kusejko, K; Battegay, M; Bernasconi, E; Boni, J; Calmy, A; Cavassini, M; Egle, A; Grabmeier-Pfistershammer, K; Haas, B; Klimkait, T; Ollinger, A; Perreau, M; Ramette, A; Flury, BB; Sarcletti, M; Scherrer, A; Schmid, P; Yerly, S; Zangerle, R; Gunthard, HF; Kouyos, RD

Cardiovascular events are declining in men with HIV aged 50 years or older in Austria
Rappold, M; Kitchen, M; Rieger, A; Schmied, B; Ollinger, A; Egle, A; Wallner, E; Kanatschnig, M; Zoufaly, A; Ledergerber, B; Zangerle, R

Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, CC; Kasper, S; Hegewisch-Becker, S; Schroeder, J; Overkamp, F; Kullmann, F; Bechstein, WO; Voehringer, M; Oellinger, R; Lordick, F; Heinemann, V; Geissler, M; Schulz-Abelius, A; Linz, B; Bernhard, H; Schoen, MR; Greil, R; Smith-Machnow, V; Schmidtmann, I; Moehler, MH

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
Eich, HT; Baues, C; Fuchs, M; Kobe, C; Greil, R; Sasse, S; Zijlstra, JM; Lohri, A; Rosenwald, A; Tresckow, BV; Diehl, V; Kuhnert, G; Dietlein, M; Borchmann, P; Engert, A

Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
Keil, F; Hartl, M; Altorjai, G; Pecherstorfer, M; Mayrbaurl, B; de Vries, A; Berghold, A; Riedl, R; Fridrik, MA; Fuereder, T; Burian, M; Greil, R

Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R-2-CHOP in subjects with previously untreated, high-risk DLBCL.
Nowakowski, GS; Willenbacher, W; Greil, R; Larsen, TS; Patel, K; Jager, U; Manges, RF; Trumper, LH; Haioun, C; Everaus, H; Kalakonda, N; Knoble, J; Brown, P; Joergensen, JM; Cunningham, D; Domper, N; Casadebaig, ML; Manzke, O; Munoz, J

Treatment with 5-Azacytidine results in expression of long terminal repeat (LTR) elements in peripheral blood mononuclear cells of patients with MDS and AML: first pilot study
Daskalakis, M; Haubitz, M; Steiner, D; Helf, M; Brocks, D; Pleyer, L; Greil, R; Plass, C; Baerlocher, GM; Leibundgut, EO

Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years
Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Fitzal, F; Bago-Horvath, Z; Singer, C; Hlauschek, D; Kronenwett, R; Bernhisel, R; Lancaster, J; Gnant, M

The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer
Devyatko, Y; Filipits, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, C; Fitzal, F; Steger, G; Gray, B; Ferree, S; Fesl, C; Soelkner, L; von Minckwitz, G; Gnant, M

A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, S; Angela, R; Rinnerthaler, G; Hackl, H; Steiner, M; Pulverer, W; Weinhaeusel, A; Klinglmayr, E; Karl, T; Ilic, S; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
View this publication in the PUBMED database

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A; Melchardt, T; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Voskova, D; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R;
Cancer Med. 2019; 8(4):-1405
View this publication in the PUBMED database

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber, D; Wacht, N; Leisch, M; Qi, Y; Maeding, N; Hufnagl, C; Jansko, B; Zaborsky, N; Villunger, A; Hartmann, TN; Greil, R; Egle, A;
Clin Cancer Res. 2019; 25(6):1901-1912
View this publication in the PUBMED database

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Leisch, M; Jansko, B; Zaborsky, N; Greil, R; Pleyer, L
Cancers (Basel). 2019; 11(2):
View this publication in the PUBMED database

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
View this publication in the PUBMED database

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno, C, Greil, R, Demirkan, F, Tedeschi, A, Anz, B, Larratt, L, Simkovic, M, Samoilova, O, Novak, J, Ben-Yehuda, D, Strugov, V, Gill, D, Gribben, JG, Hsu, E, Lih, CJ, Zhou, C, Clow, F, James, DF, Styles, L, Flinn, IW.
Lancet Oncol. 2019, 20(1): 43-56.
View this publication in the PUBMED database

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A, Foukakis, T, Moebus, V, Greil, R, Bengtsson, NO, Steger, GG, Untch, M, Johansson, H, Hellström, M, Malmström, P, Gnant, M, Loibl, S, Bergh, J.
Ann Oncol. 2019, 30(1): 109-114.
View this publication in the PUBMED database

Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2019, 131(1-2):47.
View this publication in the PUBMED database

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher, D, Klec, C, Pasculli, B, Cerk, S, Rinner, B, Karbiener, M, Ivan, C, Barbano, R, Ling, H, Wulf-Goldenberg, A, Stanzer, S, Rinnerthaler, G, Stoeger, H, Bauernhofer, T, Haybaeck, J, Hoefler, G, Jahn, SW, Parrella, P, Calin, GA, Pichler, M.
Breast Cancer Res. 2019, 21(1):20.
View this publication in the PUBMED database

Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics.
Huemer, F, Rinnerthaler, G, Lang, D, Hackl, H, Lamprecht, B, Greil, R.
Ann Oncol. 2019.
View this publication in the PUBMED database

Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
Pharmacogenomics J. 2019.
View this publication in the PUBMED database

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP, Peer, A, Weismann, C, Meissnitzer, M, Rinnerthaler, G, Webhofer, J, Westphal, T, Riedmann, M, Meissnitzer, T, Egger, H, Klaassen Federspiel, F, Reitsamer, R, Hauser-Kronberger, C, Stering, K, Hergan, K, Mlineritsch, B, Greil, R.
Breast Cancer Res. 2019, 21(1):19.
View this publication in the PUBMED database

Carcinoid heart disease involving the left heart: a case report and biomarker analysis.
Lichtenauer, M, Pichler, T, Eder, S, Mirna, M, Magnes, T, Wernly, B, Paar, V, Jung, C, Prinz, E, Seitelberger, R, Hoppe, UC.
ESC Heart Fail. 2019.
View this publication in the PUBMED database

Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Janovska, P; Verner, J; Kohoutek, J; Bryjova, L; Gregorova, M; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Ovesna, P; Blanarova, OV; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Egle, A; Pavlova, S; Poppova, L; Plevova, K; Pospisilova, S; Bryja, V

View this publication in the PUBMED database

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr, JC; Szenes, E; Tschech, L; Asslaber, D; Schlederer, M; Roos, S; Yu, X; Girbl, T; Sternberg, C; Egle, A; Aberger, F; Alon, R; Kenner, L; Greil, R; Orian-Rousseau, V; Hartmann, TN;

View this publication in the PUBMED database

Remission maintenance treatment options in chronic lymphocytic leukemia.
Egle, A; Pleyer, L; Melchardt, T; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial
Paschka, P; Schlenk, RF; Weber, D; Benner, A; Bullinger, L; Heuser, M; Gaidzik, VI; Thol, F; Agrawal, M; Teleanu, V; Lubbert, M; Fiedler, W; Radsak, M; Krauter, J; Horst, HA; Greil, R; Mayer, K; Kundgen, A; Martens, U; Heil, G; Salih, HR; Hertenstein, B; Schwanen, C; Wulf, G; Lange, E; Pfreundschuh, M; Ringhoffer, M; Girschikofsky, M; Heinicke, T; Kraemer, D; Gohring, G; Ganser, A; Dohner, K; Dohner, H

View this publication in the PUBMED database

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
Westphal, T; Rinnerthaler, G; Gampenrieder, SP; Niebauer, J; Thaler, J; Pfob, M; Fuchs, D; Riedmann, M; Mayr, B; Reich, B; Melchardt, T; Mlineritsch, B; Pleyer, L; Greil, R;

View this publication in the PUBMED database

The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe.
Cavo, M; Terpos, E; Bargay, J; Einsele, H; Cavet, J; Greil, R; de Wit, E

View this publication in the PUBMED database

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T; Magnes, T; Hufnagl, C; Thorner, AR; Ducar, M; Neureiter, D; Tränkenschuh, W; Klieser, E; Gaggl, A; Rösch, S; Rasp, G; Hartmann, TN; Pleyer, L; Rinnerthaler, G; Weiss, L; Greil, R; Egle, A;

View this publication in the PUBMED database

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;

View this publication in the PUBMED database

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stoger, H; Gerger, A; Pichler, M; Stotz, M

View this publication in the PUBMED database

Xeljanz Kasuistik
Psenak, O;

Psoriasis Arthritis, Spondylarthropathien, Osteoarthrose
Psenak, O;

Muskuloskelettale Pathophysiologie
Psenak, O;

Systemischer Lupus erythematodes, Systemische Sklerose
Psenak, O;

Pathogenese, Manifestation, Diagnostik und Therapie der Gelenksbeschwerden
Psenak, O;

Ixazomib in Combination with Thalidomide and Dexamethasone for Induction and Ixazomib Maintenance Therapy Overcomes High-Risk Cytogenetics (but not of 1q21 Gain) in Relapsed/Refractory Multiple Myeloma - AGMT_MM1
Ludwig, H; Ponisch, W; Knop, S; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Krenosz, KJ; Petzer, A; Weisel, K; Einsele, H; Greil, R; Zojer, N

Deletion of the p53 Target Gene PUMA Prevents Bone Marrow Failure in a Dyskeratosis Congenita Mouse Model
Erlacher, M; Molnar, C; Weiss, JM; Bohler, S; Steinemann, D; Gohring, G; Villunger, A; Labi, V; Niemeyer, C; Egle, A

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?
Tissino, E; Bittolo, T; Benedetti, D; Bomben, R; Forestieri, G; Szenes, E; Haerzschel, A; Santinelli, E; Rossi, MF; Chigaev, A; Sklar, LA; Zaja, F; Bulian, P; DxxxArena, GF; Chiarenza, A; Di Raimondo, F; Pozzato, G; Rossi, D; Del Poeta, G; Hartmann, TN; Zucchetto, A; Gattei, V

Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis
Haslbauer, F; Petzer, AL; Safanda, M; Tomova, A; Porubska, M; Bajory, Z; Niepel, D; Jager, C; Kalinin, D; Greil, R

Prognostic Value of Circulating Bcl-2/Igh Levels before and after Treatment in 415 Patients with Advanced Follicular Lymphoma Receiveing First-Line Immuno-Chemotherapy in 2 Prospective StiL Trails - the Effects of Riruximab Maintenance
Kobbe, G; Pechtel, S; Zohren, F; Barth, J; Burchardt, AC; Buske, C; Dienst, A; Germing, U; Greil, R; Hertenstein, B; Kauff, F; Koenigsmann, M; Lerchenmuller, C; Schroeder, TM; Haas, R; Rummel, MJ

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study
Schlenk, RF; Paschka, P; Krzykalla, J; Weber, D; Kapp-Schwoerer, S; Gaidzik, VI; Leis, C; Fiedler, W; Kindler, T; Schroeder, T; Mayer, K; Lubbert, M; Wattad, MA; Gotze, KS; Horst, HA; Koller, E; Wulf, G; Schleicher, J; Bentz, M; Greil, R; Hertenstein, B; Krauter, J; Martens, U; Nachbaur, D; Abu Samra, M; Girschikofsky, M; Benner, A; Thol, F; Heuser, M; Ganser, A; Dohner, K

mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort
Filipits, M; Rudas, M; Singer, C; Bago-Horvath, Z; Greil, R; Balic, M; Lax, SF; Wu, N; Zhao, S; Weidler, J; Bates, M; Hlauschek, D; Gnant, M; Dubsky, P

Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera - Final Phase I/II Peginvera Study Results
Gisslinger, H; Buxhofer-Ausch, V; Thaler, J; Forjan, E; Willenbacher, E; Wolf, D; Kralovics, R; Gisslinger, B; Stampfl-Mattersberger, M; Egle, A; Melchardt, T; Burgstaller, S; Schalling, M; Krauth, MT; Greil, R; Kadlecova, P; Zoerer, M; Empson, V; Grohmann-Izay, B; Klade, C

Ibrutinib plus Obinutuzumab Versus Chlorambucil plus Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results from Phase 3 iLLUMINATE
Moreno, C; Greil, R; Demirkan, F; Tedeschi, A; Anz, B; Larratt, L; Simkovic, M; Samoilova, O; Novak, J; Ben-Yehuda, D; Strugov, V; Gill, D; Gribben, JG; Hsu, E; Zhou, C; Clow, F; James, DF; Styles, L; Flinn, IW

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Burtness, B; Harrington, KJ; Greil, R; Soulieres, D; Tahara, M; De Castro, G; Psyrri, A; Rotllan, NB; Neupane, PC; Bratland, A; Fuereder, T; Hughes, BGM; Mesia, R; Ngamphaiboon, N; Rordorf, T; Ishak, WZW; Roy, A; Cheng, J; Jin, F; Rischin, D

Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naive Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study
Greil, R; Fraser, G; Leber, B; Marks, R; Quaresmini, G; Middeke, JM; Semenzato, G; Schary, W; Boyer, M; Breuleux, M; Crompton, N; Humphrey, K; Marlton, P

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
Fuchs, M; Goergen, H; Kobe, C; Eich, H; Baues, C; Greil, R; Sasse, S; Zijlstra, JM; Lohri, A; Rosenwald, A; von Tresckow, B; Diehl, V; Kuhnert, G; Dietlein, M; Borchmann, P; Engert, A

Spatial heterogeneity in diffuse large B-cell lymphoma
Magnes, T; Melchardt, T; Thorner, A; Neureiter, D; Klieser, E; Greil, R; Egle, A

Exome sequencing of tumors from the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
Egle, A; Gassner, FJ; Hopner, JP; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Zaborsky, N

Panitumumab-Associated Encephalopathy after Accidental Intra-Arterial Application through Dislocated Central Venous Access Device
Sellner, J; Pilz, G; Gschwandtner, G; Rosler, C; Schlick, K; Greil, R; Pikija, S

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Hufnagl, C; Leisch, M; Weiss, L; Melchardt, T; Moik, M; Geisberger, R; Asslaber, D; Steininger, P; Meissnitzer, T; Neureiter, D; Greil, R; Egle, A

Efficacy and safety of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer and adenocarcinoma of the small intestine
Wainberg, Z; Lassen, U; Elez, E; Italiano, A; Curigliano, G; DeBraud, F; Prager, G; Greil, R; Stein, A; Angelica, F; Schellens, JHM; Wen, PY; Boran, AD; Mookerjee, B; Burgess, P; Rangwala, F; Subbiah, V

Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
Steger, G; Petru, E; Haslbauer, F; Marth, C; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuehr, T; Petzer, A; Ruckser, R; Greil, R; Mlineritsch, B; Singer, C; Seifert, M; Andel, J; Kwasny, W; Pichler, P; Tinchon, C; Bartsch, R

The HIV continuum of care in Austria from 2010 to 2016: data and challenges
Leierer, G; van Sighem, A; Rieger, A; Schmied, B; Sarcletti, M; Ollinger, A; Haas, B; Egle, A; Rappold, M; Zangerle, R

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, a phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Pusch, R; Fridrik, M; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, C; Bartsch, R; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

Polyligand profiling differentiates cancer patients according to their benefit of treatment
Domenyuk, V; Gatalica, Z; Santhanam, R; Wei, XX; Stark, A; Kennedy, P; Toussaint, B; Levenberg, S; Wang, R; Xiao, N; Greil, R; Rinnerthaler, G; Gampenrieder, S; Heimberger, AB; Berry, DJ; Barker, A; Demetri, GD; Quackenbush, J; Marshall, JL; Poste, G; Vacirca, JL; Vidal, GA; Schwartzberg, LS; Halbert, DD; Voss, A; Miglarese, MR; Famulok, M; Mayer, G; Spetzler, D

Contrast-enhanced MRI does not accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy in early or locally advanced breast cancer
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Popovscaia, M; Meissnitzer, T; Reitsamer, R; Hauser-Kronberger, C; Egger, H; Hergan, K; Mlineritsch, B; Greil, R

The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
Dubsky, PC; Fesl, C; Singer, CF; Pfeiler, G; Kronenwett, R; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Tea, MKM; Wette, V; Petzner, AL; Sevelda, P; Egle, D; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Lax, S; Regitnig, P; Gnant, M; Filipits, M

Screening for human epidermal growth factor receptor 2 (HER2) positivity in patients with inoperable locally advanced or metastatic gastric or gastro-esophageal junction (GEJ) cancer. AGMT Gastric-5
Woll, E; Regitnig, P; Winder, T; Thaler, J; Hockl, P; Eisterer, W; Ganzer, H; Wustner, A; Andel, J; Greil, R

Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)
Rummel, M; Buske, C; Hertenstein, B; Lerchenmuller, CA; Koenigsmann, M; Lange, E; Reeb, M; Kaiser, U; Balser, C; Behringer, D; Durig, J; Gaska, T; Maschmeyer, G; Schliesser, G; Burchardt, A; Barth, J; Kauff, F; Hinke, A; Greil, R

Subgroup analysis in elderly patients with metastatic pancreatic cancer: Preliminary results of Austrian real world data with nab-paclitaxel/gemcitabine
Prager, G; Gerger, A; Eisterer, W; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubman, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Grunberger, B; Ohler, L

Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Pusch, R; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

RNA editing in CLL
Gassner, FJ; Zaborsky, N; Sychikow, I; Levanon, E; Greil, R; Geisberger, R

Two years Rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial)
Rummel, M; Koenigsmann, M; Chow, KU; Knauf, W; Lerchenmuller, CA; Losem, C; Gorner, M; Hertenstein, B; Decker, T; Ganser, A; Gaska, T; Heike, M; Lange, E; Weide, R; Willenbacher, W; Burchardt, A; Kauff, F; Barth, J; Hinke, A; Greil, R

Elucidating the contribution of AID to the clonal evolution of chronic lymphocytic leukemia
Schubert, M; Zaborsky, N; Huemer, M; Hopner, JP; Gassner, FJ; Arzt, C; Greil, R; Geisberger, R

Fracture Risk after Stopping Adjuvant Denosumab in Hormone Receptor Positive Breast Cancer Patients on Aromatase Inhibitor Therapy - an Analysis of 3,425 Postmenopausal Patients in the Phase III ABCSG-18 trial
Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Bergh, J; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF; Gnant, M

A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy - results from 3,484 postmenopausal women in the ABCSG-16 trial
Gnant, M; Steger, G; Greil, R; Fitzal, F; Mlineritsch, B; Manfreda, D; Tausch, C; Balic, M; Dubsky, P; Moik, M; Thaler, J; Egle, D; Bjelic-Radisic, V; Selim, U; Exner, R; Singer, C; Melbinger-Zeinitzer, E; Haslbauer, F; Stoger, H; Helfgott, R; Sevelda, P; Trapl, H; Wette, V; Solkner, L; Jakesz, R

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S; Lang, R; Steiner, M; Aglas, L; Ferreira, F; Wallner, M; Hawranek, T; Gadermaier, G;

View this publication in the PUBMED database

Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA;

View this publication in the PUBMED database

ASCO 2018 highlights: metastatic breast cancer
Rinnerthaler, G; Gampenrieder, SP; Greil, R

View this publication in the PUBMED database

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S; Fastner, G; Vaszi, A; Iglseder, W; Kopp, P; Holzinger, J; Dinnewitzer, A; Rinnerthaler, G; Gampenrieder, SP; Emmanuel, K; Greil, R; Sedlmayer, F; Zehentmayr, F;

View this publication in the PUBMED database

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
Hughes, RA; May, MT; Tilling, K; Taylor, N; Wittkop, L; Reiss, P; Gill, J; Schommers, P; Costagliola, D; Guest, JL; Lima, VD; Monforte, AD; Smith, C; Cavassini, M; Saag, M; Sterling, TR; Sterne, JAC;

View this publication in the PUBMED database

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Ball, B; Komrokji, RS; Ades, L; Sekeres, MA; DeZern, AE; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, SD; Fenaux, P; Prebet, T

View this publication in the PUBMED database

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis.
Rinnerthaler, G; Gampenrieder, SP; Greil, R

View this publication in the PUBMED database

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner, FJ; Schubert, M; Rebhandl, S; Spandl, K; Zaborsky, N; Catakovic, K; Blaimer, S; Hebenstreit, D; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes, J; Pleyer, L; Thépot, S; Almeida, AM; Maurillo, L; Martínez-Robles, V; Stauder, R; Itzykson, R; Pinto, R; Venditti, A; Bargay, J; Burgstaller, S; Martínez, MP; Seegers, V; Cortesão, E; Foncillas, MÁ; Gardin, C; Montesinos, P; Musto, P; Fenaux, P; Greil, R; Sanz, MA; Ramos, F;

View this publication in the PUBMED database

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S; Stauder, R; Kuehr, T; Lang, A; Machherndl-Spandl, S; Mayrbaeurl, B; Noesslinger, T; Petzer, A; Valent, P; Greil, R; Thaler, J;

View this publication in the PUBMED database

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G; Fridrik, M; Fridrik, A; Leiherer, A; Zabernigg, A; Greil, R; Eisterer, W; Tschmelitsch, J; Lang, A; Frantal, S; Burgstaller, S; Gnant, M; Thaler, J;

View this publication in the PUBMED database

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F; Weiss, L; Faber, V; Neureiter, D; Egle, A; Geissler, K; Voskova, D; Zebisch, A; Burgstaller, S; Pichler, A; Stauder, R; Sperr, W; Lang, A; Pfeilstöcker, M; Machherndl-Spandl, S; Stampfl, M; Greil, R; Pleyer, L;

View this publication in the PUBMED database

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P; Gillor, D; Hentrich, M; Wyen, C; Wolf, T; Oette, M; Zoufaly, A; Wasmuth, JC; Bogner, JR; Müller, M; Esser, S; Schleicher, A; Jensen, B; Stoehr, A; Behrens, G; Schultze, A; Siehl, J; Thoden, J; Taylor, N; Hoffmann, C;

View this publication in the PUBMED database

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP;

View this publication in the PUBMED database

Time to repeal and replace response criteria for acute myeloid leukemia?
Bloomfield, CD; Estey, E; Pleyer, L; Schuh, AC; Stein, EM; Tallman, MS; Wei, A

View this publication in the PUBMED database

Cure in metastatic breast cancer.
Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.
Greil, R; Pleyer, L; Jansko, B; Feierabend, C; Rettenbacher, L; Stiefel, O; Rass, C; Morre, P; Neureiter, D; Greil-Ressler, S;

View this publication in the PUBMED database

Risks and chances of aberrant DNA repair in cancer.
Schubert, M; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer, F; Rinnerthaler, G; Westphal, T; Hackl, H; Hutarew, G; Gampenrieder, SP; Weiss, L; Greil, R;

View this publication in the PUBMED database

Rac GTPases in Hematological Malignancies
Durand-Onayli, V; Haslauer, T; Harzschel, A; Hartmann, TN

View this publication in the PUBMED database

Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial.
Kogler, P; DeVries, AF; Eisterer, W; Thaler, J; Sölkner, L; Öfner, D;

View this publication in the PUBMED database

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;

View this publication in the PUBMED database

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M; Aglas, L; Twaroch, TE; Steiner, M; Huber, S; Hauser, M; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Wallner, M; Ferreira, F;

View this publication in the PUBMED database

Factor VII deficiency in major artery occlusion stroke.
Pikija, S; Gampenrieder, SP; Millesi, K; Pilz, G; Weis, S; Mutzenbach, JS

View this publication in the PUBMED database

PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P; Goergen, H; Kobe, C; Lohri, A; Greil, R; Eichenauer, DA; Zijlstra, JM; Markova, J; Meissner, J; Feuring-Buske, M; Hüttmann, A; Dierlamm, J; Soekler, M; Beck, HJ; Willenbacher, W; Ludwig, WD; Pabst, T; Topp, MS; Hitz, F; Bentz, M; Keller, UB; Kühnhardt, D; Ostermann, H; Schmitz, N; Hertenstein, B; Aulitzky, W; Maschmeyer, G; Vieler, T; Eich, H; Baues, C; Stein, H; Fuchs, M; Kuhnert, G; Diehl, V; Dietlein, M; Engert, A;

View this publication in the PUBMED database

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

Austrian recommendations for the management of polycythemia vera.
Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Beham-Schmid, C; Gastl, G; Geissler, K; Melchardt, T; Krauth, M; Krippl, P; Petzer, A; Rumpold, H; Wölfler, A; Gisslinger, H;

View this publication in the PUBMED database

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S; Goergen, H; Plütschow, A; Böll, B; Eichenauer, DA; Fuchs, M; Behringer, K; Zijlstra, JM; Greil, R; Markova, J; Topp, MS; Meissner, J; Neubauer, A; Baues, C; Engert, A; Borchmann, P; von Tresckow, B;

View this publication in the PUBMED database

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F; Thaler, J; Piringer, G; Hackl, H; Pleyer, L; Hufnagl, C; Weiss, L; Greil, R;

View this publication in the PUBMED database

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Pleyer, L; Vcelar, B; Majeed, M; Sordillo, P;

View this publication in the PUBMED database

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K; Magnes, T; Ratzinger, L; Jaud, B; Weiss, L; Melchardt, T; Greil, R; Egle, A;

View this publication in the PUBMED database

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
Schubert, M; Hackl, H; Gassner, FJ; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Tissino, E; Benedetti, D; Herman, SEM; Ten Hacken, E; Ahn, IE; Chaffee, KG; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Bayer, E; Härzschel, A; Gutjahr, JC; Postorino, M; Santinelli, E; Ayed, A; Zaja, F; Chiarenza, A; Pozzato, G; Chigaev, A; Sklar, LA; Burger, JA; Ferrajoli, A; Shanafelt, TD; Wiestner, A; Del Poeta, G; Hartmann, TN; Gattei, V; Zucchetto, A;

View this publication in the PUBMED database

Non-Hodgkin lymphoma risk in adults living with HIV across five continents The AIDS-defining Cancer Project Working Group of leDEA and COHERE in EuroCoord
Rohner, E; Butikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Moore, RD; Goedert, JJ; Gill, MJ; Silverberg, MJ; Patel, P; Castilho, J; Hoy, J; Sohn, A; Bani-Sadr, F; Taylor, N; Paparizos, V; Le Moing, V; Bonnet, F; Verbon, A; Vehreschild, JJ; Post, FA; Sabin, C; Mocroft, A; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Antinori, A; Quiros-Rol-Dan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Boue, F; Barger, D; Raben, D; Clifford, GM; Franceschi, S; Brockmeyer, N; Egger, M; Bohlius, J

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk, V; Gatalica, Z; Santhanam, R; Wei, XX; Stark, A; Kennedy, P; Toussaint, B; Levenberg, S; Wang, J; Xiao, NQ; Greil, R; Rinnerthaler, G; Gampenrieder, SP; Heimberger, AB; Berry, DA; Barker, A; Quackenbush, J; Marshall, JL; Poste, G; Vacirca, JL; Vidal, GA; Schwartzberg, LS; Halbert, DD; Voss, A; Magee, D; Miglarese, MR; Famulok, M; Mayer, G; Spetzler, D

View this publication in the PUBMED database

News from ASCO 2018
Balic, M; Dedic, N; De Mattos-Arruda, L; Gampenrieder, S

RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U;

View this publication in the PUBMED database

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Pulverer, W; Weinhaeusel, A; Ilic, S; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Risch, A; Greil, R

View this publication in the PUBMED database

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.
Leuk Lymphoma. 2018, 59(5):1121-1126.
View this publication in the PUBMED database

ASCO 2018 highlights: metastatic breast cancer.
Rinnerthaler, G, Gampenrieder, SP, Greil, R.
MEMO-MAG EUR MED ONC. 2018, 11(4): 276-279.

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger, GT, Licollari, A, Tan, A, Greil, R, Vcelar, B, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Majeed, M, Sordillo, PP.
Cancer Chemother Pharmacol. 2018.
View this publication in the PUBMED database

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K, Magnes, T, Ratzinger, L, Jaud, B, Weiss, L, Melchardt, T, Greil, R, Egle, A.
PLoS One. 2018, 13(11): e0206688.
View this publication in the PUBMED database

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S, Lang, R, Steiner, M, Aglas, L, Ferreira, F, Wallner, M, Hawranek, T, Gadermaier, G.
Clin Transl Allergy. 2018, 8: 39.
View this publication in the PUBMED database

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.
Westphal, T, Rinnerthaler, G, Gampenrieder, SP, Niebauer, J, Thaler, J, Pfob, M, Fuchs, D, Riedmann, M, Mayr, B, Reich, B, Melchardt, T, Mlineritsch, B, Pleyer, L, Greil, R.
Cancer Med. 2018.
View this publication in the PUBMED database

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Asamer, E, Szkandera, J, Gibiser, P, Lembeck, AL, Stojakovic, T, Kornprat, P, Lackner, C, Winder, T, Schlick, K, Stoger, H, Gerger, A, Pichler, M, Stotz, M.
WIEN KLIN WOCHENSCHR. 2018, 130(19-20): 569-574.
View this publication in the PUBMED database

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R.
BMC Cancer. 2018, 18(1): 1074.
View this publication in the PUBMED database

RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B, Piñón Hofbauer, J, Wally, V, Arzt, C, Hainzl, S, Kocher, T, Murauer, EM, Bauer, JW, Reichelt, J, Koller, U.
Int J Mol Sci. 2018, 19(3).
View this publication in the PUBMED database

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Ball, B, Komrokji, RS, Ades, L, Sekeres, MA, DeZern, AE, Pleyer, L, Vey, N, Almeida, A, Germing, U, Cluzeau, T, Platzbecker, U, Gore, SD, Fenaux, P, Prebet, T.
BLOOD ADV. 2018, 2(16): 2063-2071.
View this publication in the PUBMED database

Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Fitzal, F, Bjelic-Radisic, V, Knauer, M, Steger, G, Hubalek, M, Balic, M, Singer, C, Bartsch, R, Schrenk, P, Soelkner, L, Greil, R, Gnant, M.
Ann Surg. 2018.
View this publication in the PUBMED database

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M, Egle, A, Greil, R.
Future Oncol. 2018.
View this publication in the PUBMED database

News from ASCO 2018.
Balic, M, Dedic, N, De Mattos-Arruda, L, Gampenrieder, S.
BREAST CARE. 2018, 13(4): 298-302.

Remission maintenance treatment options in chronic lymphocytic leukemia.
Egle, A, Pleyer, L, Melchardt, T, Hartmann, TN, Greil, R.
Cancer Treat Rev. 2018, 70:5-66.
View this publication in the PUBMED database

Extensive leptomeningeal intracranial and spinal metastases in a patient with a supratentorial glioblastoma multiforme, IDH-wildtype: A case report.
Schwartz, C, Romagna, A, Machegger, L, Weiss, L, Huemer, F, Fastner, G, Kleindienst, W, Serge, W, Greil, R, Winkler, PA.
World Neurosurg. 2018.
View this publication in the PUBMED database

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S, Goergen, H, Plütschow, A, Böll, B, Eichenauer, DA, Fuchs, M, Behringer, K, Zijlstra, JM, Greil, R, Markova, J, Topp, MS, Meissner, J, Neubauer, A, Baues, C, Engert, A, Borchmann, P, von Tresckow, B.
J Clin Oncol. 2018, 36(25):2603-2611.
View this publication in the PUBMED database

Austrian recommendations for the management of polycythemia vera.
Burgstaller, S, Buxhofer-Ausch, V, Sliwa, T, Beham-Schmid, C, Gastl, G, Geissler, K, Melchardt, T, Krauth, M, Krippl, P, Petzer, A, Rumpold, H, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
Krauth, MT, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A, Gisslinger, H.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer.
Greil, R, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Bolger, GT, Vcelar, B, Sordillo, PP.
Cancer Chemother Pharmacol. 2018.
View this publication in the PUBMED database

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Paschka, P, Schlenk, RF, Weber, D, Benner, A, Bullinger, L, Heuser, M, Gaidzik, VI, Thol, F, Agrawal, M, Teleanu, V, Lubbert, M, Fiedler, W, Radsak, M, Krauter, J, Horst, HA, Greil, R, Mayer, K, Kundgen, A, Martens, U, Heil, G, Salih, HR, Hertenstein, B, Schwanen, C, Wulf, G, Lange, E, Pfreundschuh, M, Ringhoffer, M, Girschikofsky, M, Heinicke, T, Kraemer, D, Gohring, G, Ganser, A, Dohner, K, Dohner, H.
LEUKEMIA. 2018, 32(7): 1621-1630.
View this publication in the PUBMED database

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A, Steurer, M, Melchardt, T, Weiss, L, Gassner, FJ, Zaborsky, N, Geisberger, R, Catakovic, K, Hartman, TN, Pleyer, L, Voskova, D, Thaler, J, Lang, A, Girschikofsky, M, Petzer, A, Greil, R.
Ann Hematol. 2018.
View this publication in the PUBMED database

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S, Fastner, G, Vaszi, A, Iglseder, W, Kopp, P, Holzinger, J, Dinnewitzer, A, Rinnerthaler, G, Gampenrieder, SP, Emmanuel, K, Greil, R, Sedlmayer, F, Zehentmayr, F.
Strahlenther Onkol. 2018, 194(7):62-637.
View this publication in the PUBMED database

Factor VII deficiency in major artery occlusion stroke.
Pikija, S, Gampenrieder, SP, Millesi, K, Pilz, G, Weis, S, Mutzenbach, JS.
Am J Hematol. 2018, 93(6):843-845.
View this publication in the PUBMED database

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F.
J Allergy Clin Immunol. 2018, 141(4):1488-1491.e5.
View this publication in the PUBMED database

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.
Gampenrieder, SP, Rinnerthaler, G, Hackl, H, Pulverer, W, Weinhaeusel, A, Ilic, S, Hufnagl, C, Hauser-Kronberger, C, Egle, A, Risch, A, Greil, R.
THERANOSTICS. 2018, 8(8): 2278-2288.

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk, V, Gatalica, Z, Santhanam, R, Wei, XX, Stark, A, Kennedy, P, Toussaint, B, Levenberg, S, Wang, J, Xiao, NQ, Greil, R, Rinnerthaler, G, Gampenrieder, SP, Heimberger, AB, Berry, DA, Barker, A, Quackenbush, J, Marshall, JL, Poste, G, Vacirca, JL, Vidal, GA, Schwartzberg, LS, Halbert, DD, Voss, A, Magee, D, Miglarese, MR, Famulok, M, Mayer, G, Spetzler, D.
Nat Commun. 2018, 9(1):1219.
View this publication in the PUBMED database

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner, FJ, Schubert, M, Rebhandl, S, Spandl, K, Zaborsky, N, Catakovic, K, Blaimer, S, Hebenstreit, D, Greil, R, Geisberger, R.
Mol Cancer Res. 2018, 16(3):428-438.
View this publication in the PUBMED database

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.
Leuk Lymphoma. 2018, 59(5):1121-1126.
View this publication in the PUBMED database

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G, Fridrik, M, Fridrik, A, Leiherer, A, Zabernigg, A, Greil, R, Eisterer, W, Tschmelitsch, J, Lang, A, Frantal, S, Burgstaller, S, Gnant, M, Thaler, J.
Support Care Cancer. 2018, 26(4):1345-1352.
View this publication in the PUBMED database

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes, J, Pleyer, L, Thépot, S, Almeida, AM, Maurillo, L, Martínez-Robles, V, Stauder, R, Itzykson, R, Pinto, R, Venditti, A, Bargay, J, Burgstaller, S, Martínez, MP, Seegers, V, Cortesão, E, Foncillas, MÁ, Gardin, C, Montesinos, P, Musto, P, Fenaux, P, Greil, R, Sanz, MA, Ramos, F,
Leuk Lymphoma. 2018, 59(5):1113-1120.
View this publication in the PUBMED database

The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe.
Cavo, M, Terpos, E, Bargay, J, Einsele, H, Cavet, J, Greil, R, de Wit, E.
Expert Rev Hematol. 2018, 11(3):219-237.
View this publication in the PUBMED database

Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P, Gillor, D, Hentrich, M, Wyen, C, Wolf, T, Oette, M, Zoufaly, A, Wasmuth, JC, Bogner, JR, Müller, M, Esser, S, Schleicher, A, Jensen, B, Stoehr, A, Behrens, G, Schultze, A, Siehl, J, Thoden, J, Taylor, N, Hoffmann, C.
Haematologica. 2018.
View this publication in the PUBMED database

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T, Magnes, T, Hufnagl, C, Thorner, AR, Ducar, M, Neureiter, D, Tränkenschuh, W, Klieser, E, Gaggl, A, Rösch, S, Rasp, G, Hartmann, TN, Pleyer, L, Rinnerthaler, G, Weiss, L, Greil, R, Egle, A.
Eur J Cancer. 2018, 93:69-78.
View this publication in the PUBMED database

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F, Weiss, L, Faber, V, Neureiter, D, Egle, A, Geissler, K, Voskova, D, Zebisch, A, Burgstaller, S, Pichler, A, Stauder, R, Sperr, W, Lang, A, Pfeilstöcker, M, Machherndl-Spandl, S, Stampfl, M, Greil, R, Pleyer, L.
Wien Klin Wochenschr. 2018.
View this publication in the PUBMED database

PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P, Goergen, H, Kobe, C, Lohri, A, Greil, R, Eichenauer, DA, Zijlstra, JM, Markova, J, Meissner, J, Feuring-Buske, M, Hüttmann, A, Dierlamm, J, Soekler, M, Beck, HJ, Willenbacher, W, Ludwig, WD, Pabst, T, Topp, MS, Hitz, F, Bentz, M, Keller, UB, Kühnhardt, D, Ostermann, H, Schmitz, N, Hertenstein, B, Aulitzky, W, Maschmeyer, G, Vieler, T, Eich, H, Baues, C, Stein, H, Fuchs, M, Kuhnert, G, Diehl, V, Dietlein, M, Engert, A.
Lancet. 2018, 390(10114): 2790-2802.
View this publication in the PUBMED database

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F, Thaler, J, Piringer, G, Hackl, H, Pleyer, L, Hufnagl, C, Weiss, L, Greil, R.
BMC Cancer. 2018, 18(1): 11.
View this publication in the PUBMED database

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr, JC, Szenes, E, Tschech, L, Asslaber, D, Schlederer, M, Roos, S, Yu, X, Girbl, T, Sternberg, C, Egle, A, Aberger, F, Alon, R, Kenner, L, Greil, R, Orian-Rousseau, V, Hartmann, TN.
Blood. 2018.
View this publication in the PUBMED database

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Tissino, E, Benedetti, D, Herman, SEM, Ten Hacken, E, Ahn, IE, Chaffee, KG, Rossi, FM, Dal Bo, M, Bulian, P, Bomben, R, Bayer, E, Härzschel, A, Gutjahr, JC, Postorino, M, Santinelli, E, Ayed, A, Zaja, F, Chiarenza, A, Pozzato, G, Chigaev, A, Sklar, LA, Burger, JA, Ferrajoli, A, Shanafelt, TD, Wiestner, A, Del Poeta, G, Hartmann, TN, Gattei, V, Zucchetto, A.
J Exp Med. 2018.
View this publication in the PUBMED database

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger, GT, Licollari, A, Tan, A, Greil, R, Pleyer, L, Vcelar, B, Majeed, M, Sordillo, P.
Anticancer Res. 2018, 38(1): 12-130.
View this publication in the PUBMED database

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J;

View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S; Rinnerthaler, M; Bischof, J; Streubel, MK; Breitenbach-Koller, H; Geisberger, R; Aigner, E; Cadamuro, J; Richter, K; Sopjani, M; Haschke-Becher, E; Felder, TK; Breitenbach, M;

View this publication in the PUBMED database

Azacitidine in adult patients with acute myeloid leukemia.
Schuh, AC; Dohner, H; Pleyer, L; Seymour, JF; Fenaux, P; Dombreth, H

View this publication in the PUBMED database

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Thieblemont, C; Tilly, H; Gomes da Silva, M; Casasnovas, RO; Fruchart, C; Morschhauser, F; Haioun, C; Lazarovici, J; Grosicka, A; Perrot, A; Trotman, J; Sebban, C; Caballero, D; Greil, R; van Eygen, K; Cohen, AM; Gonzalez, H; Bouabdallah, R; Oberic, L; Corront, B; Choufi, B; Lopez-Guillermo, A; Catalano, J; Van Hoof, A; Briere, J; Cabeçadas, J; Salles, G; Gaulard, P; Bosly, A; Coiffier, B;

View this publication in the PUBMED database

ASCO 2017-making a difference in cancer care with you
Rinnerthaler, G

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group.
Engert, A; Goergen, H; Markova, J; Pabst, T; Meissner, J; Zijlstra, JM; Král, Z; Eichenauer, DA; Soekler, M; Greil, R; Kreissl, S; Scheuvens, R; Eich, H; Kobe, C; Dietlein, M; Stein, H; Fuchs, M; Diehl, V; Borchmann, P;

View this publication in the PUBMED database

ASCO 2017-highlights of gynecological cancer.
Radl, B; Mlineritsch, B

View this publication in the PUBMED database

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T; Egle, A; Greil, R; Melchardt, T;

View this publication in the PUBMED database

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A;

View this publication in the PUBMED database

The sound of tumor cell-microenvironment communication - composed by the Cancer Cluster Salzburg research network.
Wessler, S; Aberger, F; Hartmann, TN;

View this publication in the PUBMED database

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.
Catakovic, K; Gassner, FJ; Ratswohl, C; Zaborsky, N; Rebhandl, S; Schubert, M; Steiner, M; Gutjahr, JC; Pleyer, L; Egle, A; Hartmann, TN; Greil, R; Geisberger, R;

View this publication in the PUBMED database

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M; Weiss, L; Lindlbauer, N; Jungbauer, C; Egle, A; Rohde, E; Greil, R; Grabmer, C; Pleyer, L;

View this publication in the PUBMED database

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U;

View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP; Hufnagl, C; Brechelmacher, S; Huemer, F; Hackl, H; Rinnerthaler, G; Romeder, F; Monzo Fuentes, C; Morre, P; Hauser-Kronberger, C; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

ASCO-update: gastrointestinal tumors.
Weiss, L; Huemer, F; Greil, R;

View this publication in the PUBMED database

Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.
Padberg, S; Mick, I; Frenzel, C; Greil, R; Hilberath, J; Schaefer, C;

View this publication in the PUBMED database

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation
Riedl, D; Giesinger, JM; Wintner, LM; Loth, FL; Rumpold, G; Greil, R; Nickels, A; Licht, T; Holzner, B

View this publication in the PUBMED database

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R;

View this publication in the PUBMED database

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Majeed, M; Helson, L;

View this publication in the PUBMED database

When the guardian sleeps: Reactivation of the p53 pathway in cancer.
Merkel, O; Taylor, N; Prutsch, N; Staber, PB; Moriggl, R; Turner, SD; Kenner, L

View this publication in the PUBMED database

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
Rohner, E; Bütikofer, L; Schmidlin, K; Sengayi, M; Maskew, M; Giddy, J; Garone, D; Moore, RD; D’Souza, G; Goedert, JJ; Achenbach, C; Gill, MJ; Kitahata, MM; Patel, P; Silverberg, MJ; Castilho, J; McGowan, C; Chen, YA; Law, M; Taylor, N; Paparizos, V; Bonnet, F; Verbon, A; Fätkenheuer, G; Post, FA; Sabin, C; Mocroft, A; Moing, VL; Dronda, F; Obel, N; Grabar, S; Spagnuolo, V; Antinori, A; Quiros-Roldan, E; Mussini, C; Miro, JM; Meyer, L; Hasse, B; Konopnicki, D; Roca, B; Barger, D; Raben, D; Clifford, GM; Franceschi, S; Brockmeyer, N; Chakraborty, R; Egger, M; Bohlius, J;

View this publication in the PUBMED database

Amb a 1 isoforms: Unequal siblings with distinct immunological features.
Wolf, M; Twaroch, TE; Huber, S; Reithofer, M; Steiner, M; Aglas, L; Hauser, M; Aloisi, I; Asam, C; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Jahn-Schmid, B; Wallner, M; Ferreira, F;

View this publication in the PUBMED database

Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion-Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction.
Wernly, B; Gonçalves, I; Kiss, A; Paar, V; Mösenlechner, T; Leisch, M; Santer, D; Motloch, L; Klein, KU; Tretter, EV; Kretzschmar, D; Podesser, B; Jung, C; Hoppe, UC; Lichtenauer, M;

View this publication in the PUBMED database

Multiple myeloma of the mandibular condyle: a rare presentation.
Bottini, GB; Steiner, C; Melchardt, T; Gaggl, A;

View this publication in the PUBMED database

Antiangiogenic therapy in breast cancer.
Gampenrieder, SP; Westphal, T; Greil, R;

View this publication in the PUBMED database

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkins lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Borchmann, P; Haverkamp, H; Lohri, A; Mey, U; Kreissl, S; Greil, R; Markova, J; Feuring-Buske, M; Meissner, J; Dührsen, U; Ostermann, H; Keller, U; Maschmeyer, G; Kuhnert, G; Dietlein, M; Kobe, C; Eich, H; Baues, C; Stein, H; Fuchs, M; Diehl, V; Engert, A;

View this publication in the PUBMED database

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Hackl, H; Greil, R; Barth, J; Rummel, M;

View this publication in the PUBMED database

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Almeida, AM; Prebet, T; Itzykson, R; Ramos, F; Al-Ali, H; Shammo, J; Pinto, R; Maurillo, L; Wetzel, J; Musto, P; Van De Loosdrecht, AA; Costa, MJ; Esteves, S; Burgstaller, S; Stauder, R; Autzinger, EM; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez-Campelo, M; Thepot, S; Ades, L; Sperr, WR; Valent, P; Fenaux, P; Sekeres, MA; Greil, R; Pleyer, L

View this publication in the PUBMED database

SABCS 2016: systemic therapy for metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Greil, R

View this publication in the PUBMED database

Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger, F; Hutterer, E; Sternberg, C; Del Burgo, PJ; Hartmann, TN;

View this publication in the PUBMED database

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.
Egle, A

View this publication in the PUBMED database

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F; Dejaco, M; Grabmer, C; Melchardt, T; Neureiter, D; Mayer, G; Egle, A; Greil, R; Weiss, L;

View this publication in the PUBMED database

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.
Ludwig, H; Weisel, K; Petrucci, MT; Leleu, X; Cafro, AM; Garderet, L; Leitgeb, C; Foa, R; Greil, R; Yakoub-Agha, I; Zboralski, D; Vauléon, S; Dümmler, T; Beyer, D; Kruschinski, A; Riecke, K; Baumann, M; Engelhardt, M;

View this publication in the PUBMED database

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff, F; Leisch, M; Greil, R; Risch, A; Pleyer, L;

View this publication in the PUBMED database

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, L; Dohner, H; Dombret, H; Seymour, JF; Schuh, AC; Beach, CL; Swern, AS; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Spandl, SM; Zebisch, A; Pichler, A; Pfeilstocker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R

View this publication in the PUBMED database

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Kiesewetter, B; Willenbacher, E; Willenbacher, W; Egle, A; Neumeister, P; Voskova, D; Mayerhoefer, ME; Simonitsch-Klupp, I; Melchardt, T; Greil, R; Raderer, M;

View this publication in the PUBMED database

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Kazianka, L; Drucker, C; Skrabs, C; Thomas, W; Melchardt, T; Struve, S; Bergmann, M; Staber, PB; Porpaczy, E; Einberger, C; Heinz, M; Hauswirth, A; Raderer, M; Pabinger, I; Thalhammer, R; Egle, A; Wendtner, CM; Follows, G; Hoermann, G; Quehenberger, P; Jilma, B; Jaeger, U;

View this publication in the PUBMED database

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N; Kremser, I; Auer, S; Hoermann, G; Greil, R; Haschke-Becher, E; Esterbauer, H; Kenner, L; Oberkofler, H;

View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R; Hutterer, E; Hartmann, TN; Pleyer, L;

View this publication in the PUBMED database

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K; Klieser, E; Neureiter, D; Geisberger, R;

View this publication in the PUBMED database

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Head-to-head Studien
Psenak, O;

Uveitis - Differentialdiagnose und Therapie
Psenak, O;

Rheuma: Schmerz und Behinderung müssen nicht sein! Neuestes zu Diagnose und Therapie
Psenak, O;

CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation
Gutjahr, JC; Szenes, E; Tschech, L; Schlederer, M; Roos, S; Asslaber, D; Girbl, T; Greil, R; Alon, R; Kenner, L; Orian-Rousseau, V; Hartmann, TN

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Steiner, M; Monzo Fuentes, C; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R;

T-cell immune response: a prognostic factor for pathological regression in previously adjuvant treated colorectal cancer liver metastasis
Klieser, E; Krenn, P; Urbas, R; Primavesi, F, Stättner, S; Sotlar, K; Neureiter, D; Hartmann, TN

EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE
Ball, B; Komrokji, R; Ades, L; Sekeres, M; DeZern, A; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, S; Fenaux, P; Prebet, T

Austrian interdisciplinary Recommendations on the Use of Medications during the Wish to have Children as well as in Pregnancy and Lactation Period - Results of a gastroenterological-rheumatologic-dermatological Consensus
Sautner, J; Puchner, R; Grochenig, HP; Helmy-Bader, Y; Hermann, J; Hogenauer, C; Koch, R; Reinisch, S; Studnicka-Benke, A; Weger, W; Dejaco, C

Extracellular vesicles as biomarkers for the detection of epidermolysis bullosa-associated squamous cell carcinoma
Sun, Y; Woess, K; Wimmer, M; Zauner, R; Feinle, A; Wally, V; South, A; Furihata, T; Hofbauer, JP; Gruber, C

CRISPR/Cas9 mediated gene correction of COL7A1
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; del Rio, M; Duarte, BG; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U

Viral antigen-specific pre-vaccination prevents engraftment of tumor cells expressing the cognate antigen in mice
Leb-Reichl, V; Kienzl, M; Stoecklinger, A; Kitzmueller, S; Gratz, IK; Brachtl, G; Zaborsky, N; Reichelt, J; Gruber, C; Hofbauer, JP

Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

RNA trans-splicing-mediated COL7A1 repair in a dystrophic epidermolysis bullosa mouse model
Peking, P; Koller, U; Kocher, T; Nystroem, A; Reichelt, J; Bauer, JW; Murauer, EM

Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast cancer (ABCSG-34)
Bjelic-Radisic, V; Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoger, H; Pichler, A; Petru, E; Greil, R; Wette, V; Petzer, A; Sevelda, P; Egle, D; Dubsky, P; Fitzal, F; Jakesz, R; Balic, M; Frantal, S; Solkner, L; Gnant, M

CTCA toxicity scoring and EORTC quality of life questionnaire: A comparison of physiciansxxx and patientsxxx scoring of toxicity in the "Panther trial"
Brandberg, Y; Loibl, S; Foukakis, T; Johansson, H; Gnant, M; Singer, CF; von Minckwitz, G; Bengtsson, NO; Karlsson, E; Mlineritsch, B; Hellstrom, M; Steger, G; Carlsson, L; Egle, D; Greil, R; Bergh, J

Real life registry data of primary localisation of a well-defined colon cancer population of western Austria (Salzburg, Tyrol and Vorarlberg), eastern Switzerland (St. Gallen and Graubunden) and Liechtenstein
Hartmann, BL; Oberaigner, W; Frick, H; Weiss, L; Winder, T; Philipp-Abbrederis, K; Herrmann, C; Huynh, MQ; Spizzo, G; Lang, CM; Seeber, A; Schneider, J; Woll, E; Mosler, P; Greil, R; Rossle, M; Rumpold, H; Gastl, G; von Moos, R; Lang, AH

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Steiner, M; Fuentes, CM; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U

Enhanced genome editing using split Staphylococcus aureus Cas9 delivered in self-complementary AAV vectors
Liemberger, B; Arzt, C; Hainzl, S; Wally, V; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

NGS ANALYSIS OF 474 BONE MARROW SAMPLES FROM 157 AML PATIENTS TREATED WITH AZACITIDINE-IMPACT OF AGE ON MUTATIONAL LOAD
Pleyer, L; Gassner, FJ; Burgstaller, S; Wedler, H; Hartmann, TN; Jansko, B; Neureiter, D; Thaler, J; Greil, R

SUCCESSFUL LONG-TERM MAINTENANCE OF PV PATIENTS WITH A MONTHLY SCHEDULE OF ROPEGINTERFERON ALFA-2B-AN UPDATE FROM THE PEGINVERA STUDY
Buxhofer-Ausch, V; Grohmann-Izay, B; Thaler, J; Schloegl, E; Gastl, G; Wolf, D; Kralovics, R; Gisslinger, B; Ban, S; Egle, A; Melchardt, T; Burgstaller, S; Willenbacher, E; Schalling, M; Krauth, MT; Greil, R; Zoerer, M; Kadlecova, P; Klade, C; Gisslinger, H

INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE
Tissino, E; Benedetti, D; Herman, SE; ten Hacken, E; Ahn, IE; Chaffee, KG; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Bayer, E; Harzschel, A; Gutjahr, JC; Postorino, M; Santinelli, E; Ayed, A; Zaja, F; Chiarenza, A; Chigaev, A; Sklar, LA; Burger, JA; Ferrajoli, A; Shanafelt, TD; Wiestner, A; Del Poeta, G; Hartmann, TN; Gattei, V; Zucchetto, A

ALL ORAL COMBINATION OF IXAZOMIB PLUS THALIDOMIDE AND DEXAMETHASONE FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INTERIM DATA OF AN ONGOING PHASE II TRIAL
Ludwig, H; Poenisch, W; Knop, S; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Fridrik, M; Petzer, A; Weisel, K; Rauch, E; Greil, R; Zojer, N

R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting
Petzer, A; Herndlhofer, S; Weltertnann, A; Sliwa, T; Schmidt, S; Greil, R; Wolfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR

DNA methylation signature predicting bevacizumab efficacy in metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Pulverer, W; Weinhusel, A; Hufnagl, C; Hackl, H; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stoeger, H; Pichler, A; Petru, E; Greil, R; Rudas, M; Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Michael, G

CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation
Roos, S; Schlederer, M; Hartmann, T; Gutjahr, JC; Szenes, E; Tschech, L; Girbl, T; Greil, R; Kenner, L; Orian-Rousseau, V; Ronen, A

Casein Kinase 1 delta/epsilon inhibition blocks CLL chemotaxis and delays leukemia onset in the E mu-TCL1 mouse model of chronic lymphocytic leukemia
Janovska, P; Verner, J; Kohoutek, J; Bryjoval, L; Dzimkova, M; Skabrahova, H; Radaszkiewicz, T; Nemcova, T; Hoferova, Z; Vasickova, K; Smyckova, L; Gregorova, M; Egle, A; Pavlova, S; Poppova, L; Pospisilova, S; Bryja, V

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R

Ex vivo COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa
Hainzl, S; Peking, P; Kocher, T; Murauer, E; Larcher, F; Duarte, B; Steiner, M; Bauer, J; Reichelt, J; Koller, U

TIGIT as a new target for checkpoint inhibition for chronic lymphocytic leukemia
Catakovic, K; Gassner, F; Rathswohl, C; Greil, R; Hartmann, T; Geisberger, R

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M, Aglas, L, Twaroch, TE, Steiner, M, Huber, S, Hauser, M, Parigiani, MA, Hofer, H, Ebner, C, Bohle, B, Briza, P, Neubauer, A, Stolz, F, Wallner, M, Ferreira, F.
J Allergy Clin Immunol. 2017.
View this publication in the PUBMED database

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
Rohner, E, Bütikofer, L, Schmidlin, K, Sengayi, M, Maskew, M, Giddy, J, Garone, D, Moore, RD, D’Souza, G, Goedert, JJ, Achenbach, C, Gill, MJ, Kitahata, MM, Patel, P, Silverberg, MJ, Castilho, J, McGowan, C, Chen, YA, Law, M, Taylor, N, Paparizos, V, Bonnet, F, Verbon, A, Fätkenheuer, G, Post, FA, Sabin, C, Mocroft, A, Moing, VL, Dronda, F, Obel, N, Grabar, S, Spagnuolo, V, Antinori, A, Quiros-Roldan, E, Mussini, C, Miro, JM, Meyer, L, Hasse, B, Konopnicki, D, Roca, B, Barger, D, Raben, D, Clifford, GM, Franceschi, S, Brockmeyer, N, Chakraborty, R, Egger, M, Bohlius, J.
Clin Infect Dis. 2017, 65(8):-1326.
View this publication in the PUBMED database

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E, Thaler, J, Keil, F, Gruenberger, B, Hejna, M, Eisterer, W, Fridrik, MA, Ulmer, H, Trommet, V, Huemer, F, Weiss, L, Greil, R.
Anticancer Res. 2017, 37(10):5553-5558.
View this publication in the PUBMED database

ASCO-update: gastrointestinal tumors.
Weiss, L, Huemer, F, Greil, R.
Memo. 2017, 10(4):240-243.
View this publication in the PUBMED database

Multiple myeloma of the mandibular condyle: a rare presentation.
Bottini, GB, Steiner, C, Melchardt, T, Gaggl, A.
Br J Oral Maxillofac Surg. 2017, 55(10):1046-1047.
View this publication in the PUBMED database

ASCO 2017-making a difference in cancer care with you.
Rinnerthaler, G.
MEMO-MAG EUR MED ONC. 2017, 10(4): 187-189.

ASCO 2017-highlights of gynecological cancer.
Radl, B, Mlineritsch, B.
Memo. 2017, 10(4):237-239.
View this publication in the PUBMED database

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T, Egle, A, Greil, R, Melchardt, T.
Memo. 2017, 10(4):220-223.
View this publication in the PUBMED database

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling.
Seeber, A, Gastl, G, Eisterer, W, Gampenrieder, SP, Gerger, A, Kieler, M, Pichler, M, Prager, GW, Untergasser, G, Weltermann, A, Greil, R.
MEMO-MAG EUR MED ONC. 2017, 10(4): 255-258.

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y, Duinkerken, S, Hoepflinger, V, Mayr, M, Korotchenko, E, Kurtaj, A, Pablos, I, Steiner, M, Stoecklinger, A, Lübbers, J, Schmid, M, Ritter, U, Scheiblhofer, S, Ablinger, M, Wally, V, Hochmann, S, Raninger, AM, Strunk, D, van Kooyk, Y, Thalhamer, J, Weiss, R.
J Control Release. 2017, 266:87-99.
View this publication in the PUBMED database

When the guardian sleeps: Reactivation of the p53 pathway in cancer.
Merkel, O, Taylor, N, Prutsch, N, Staber, PB, Moriggl, R, Turner, SD, Kenner, L.
Mutat Res. 2017, 773:1-13.
View this publication in the PUBMED database

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger, GT, Licollari, A, Tan, AM, Greil, R, Vcelar, B, Majeed, M, Helson, L.
ANTICANCER RES. 2017, 37(7): 3483-3492.
View this publication in the PUBMED database

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.
Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B.
WIEN KLIN WOCHENSCHR. 2017, 129(19-20): 692-701.

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2017, 17(4):344-350.
View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
Cell Commun Signal. 2017, 15(1):5.
View this publication in the PUBMED database

Azacitidine in adult patients with acute myeloid leukemia.
Schuh, AC, Dohner, H, Pleyer, L, Seymour, JF, Fenaux, P, Dombreth, H.
Crit Rev Oncol Hematol. 2017, 116:159-177.
View this publication in the PUBMED database

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U.
Mol Ther. 2017.
View this publication in the PUBMED database

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L.
Leuk Res. 2017, 59:12-19.
View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2017, 17(4):344-350.
View this publication in the PUBMED database

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
nnerthaler, G, Romeder, F, M.
J Clin Oncol. 2017, 35(22):2473-2481.
View this publication in the PUBMED database

SABCS 2016: systemic therapy for metastatic breast cancer.
Gampenrieder, SP, Rinnerthaler, G, Greil, R.
MEMO-MAG EUR MED ONC. 2017, 10(2): 86-89.

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
Anticancer Res. 2017, 37(5):2683-2691.
View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M,
Front Oncol. 2017, 7: 111.
View this publication in the PUBMED database

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A.
PLoS One. 2017, 12(7):e0180995.
View this publication in the PUBMED database

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A.
Pharmacogenomics J. 2017.
View this publication in the PUBMED database

Differences in stem cell processing lead to distinct secretomes secretion - implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.
Wernly, B, Gonçalves, I, Kiss, A, Paar, V, Mösenlechner, T, Leisch, M, Santer, D, Motloch, L, Klein, KU, Tretter, EV, Kretzschmar, D, Podesser, B, Jung, C, Hoppe, UC, Lichtenauer, M.
Biotechnol J. 2017.
View this publication in the PUBMED database

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L.
INT J MOL SCI. 2017, 18(4): 837.

Amb a 1 isoforms: unequal siblings with distinct immunological features.
Wolf, M, Twaroch, TE, Huber, S, Reithofer, M, Steiner, M, Aglas, L, Hauser, M, Aloisi, I, Asam, C, Hofer, H, Parigiani, MA, Ebner, C, Bohle, B, Briza, P, Angela, N, Stolz, F, Jahn-Schmid, B, Wallner, M, Ferreira, F.
Allergy. 2017.
View this publication in the PUBMED database

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.
Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, PB, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, CM, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U.
Leukemia. 2017, 31(5):1117-1122.
View this publication in the PUBMED database

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.
Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M.
Front Oncol. 2017, 7:111.
View this publication in the PUBMED database

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J.
Anticancer Res. 2017, 37(5):2683-2691.
View this publication in the PUBMED database

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.
Egle, A.
Memo. 2017, 10(1):8-12.
View this publication in the PUBMED database

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, L, Dohner, H, Dombret, H, Seymour, JF, Schuh, AC, Beach, CL, Swern, AS, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Spandl, SM, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
INT J MOL SCI. 2017, 18(2): 415.

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Hackl, H, Greil, R, Barth, J, Rummel, M.
Ann Hematol. 2017.
View this publication in the PUBMED database

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.
Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauleon, S, Duemmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M.
Leukemia. 2017, 31(4):997-1000.
View this publication in the PUBMED database

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff, F, Leisch, M, Greil, R, Risch, A, Pleyer, L.
Cell Commun Signal. 2017, 15(1):13.
View this publication in the PUBMED database

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2017, 75(1):e13-e20.
View this publication in the PUBMED database

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L.
Cell Commun Signal. 2017, 15(1): 5.
View this publication in the PUBMED database

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Kiesewetter, B, Willenbacher, E, Willenbacher, W, Egle, A, Neumeister, P, Voskova, D, Mayerhoefer, ME, Simonitsch-Klupp, I, Melchardt, T, Greil, R, Raderer, M.
Blood. 2017, 129(3):383-385.
View this publication in the PUBMED database

Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger, F, Hutterer, E, Sternberg, C, Del Burgo, PJ, Hartmann, TN.
Cell Commun Signal. 2017, 15(1): 8.
View this publication in the PUBMED database

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Catakovic, K, Klieser, E, Neureiter, D, Geisberger, R.
Cell Commun Signal. 2017, 15(1):.
View this publication in the PUBMED database

Diagnostic challenges in vacuolar myelopathy: a didactic case report.
Ernst, F; Klausner, F; Kleindienst, W; Bartsch, H; Taylor, N; Trinka, E;

View this publication in the PUBMED database

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.
Kocher, T; Asslaber, D; Zaborsky, N; Flenady, S; Denk, U; Reinthaler, P; Ablinger, M; Geisberger, R; Bauer, JW; Seiffert, M; Hartmann, TN; Greil, R; Egle, A; Piñón Hofbauer, J;

View this publication in the PUBMED database

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Zielinski, C; Láng, I; Inbar, M; Kahán, Z; Greil, R; Beslija, S; Stemmer, SM; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Petruzelka, L; Eniu, A; Nisenbaum, B; Dank, M; Anghel, R; Messinger, D; Brodowicz, T;

View this publication in the PUBMED database

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter
Zucchetto, A; Tissino, E; Hartmann, TN; Chigaev, A; Del Poeta, G; Colombatti, A; Gattei, V

View this publication in the PUBMED database

CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
Thangavadivel, S; Zelle-Rieser, C; Olivier, A; Postert, B; Untergasser, G; Kern, J; Brunner, A; Gunsilius, E; Biedermann, R; Hajek, R; Pour, L; Willenbacher, W; Greil, R; Jöhrer, K;

View this publication in the PUBMED database

CD44: More than a mere stem cell marker.
Morath, I; Hartmann, TN; Orian-Rousseau, V;

View this publication in the PUBMED database

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Rachar, V; Czejka, M; Kitzmueller, M; Buchner, P; Lichtneckert, M; Greil, R; Geiler, H; Dittrich, C;

View this publication in the PUBMED database

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W; Thangavadivel, S; Greil, R; Willenbacher, E; Weger, R; Manzl, C; Jöhrer, K; Brunner, A;

View this publication in the PUBMED database

DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige, V; Vincent, M; Alexandre, P; Tejpar, S; Landolfi, S; Le Malicot, K; Greil, R; Cuyle, PJ; Yilmaz, M; Faroux, R; Matzdorff, A; Salazar, R; Lepage, C; Taieb, J; Laurent-Puig, P;

View this publication in the PUBMED database

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky, N; Gassner, FJ; Asslaber, D; Reinthaler, P; Denk, U; Flenady, S; Hofbauer, JP; Danner, B; Rebhandl, S; Harrer, A; Geisberger, R; Greil, R; Egle, A;

View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A;

View this publication in the PUBMED database

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A; Catusse, J; Hutterer, E; Paunovic, M; Zirlik, K; Eibel, H; Krenn, PW; Hartmann, TN; Burger, M;

View this publication in the PUBMED database

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S; Pilz, G; Gschwandtner, G; Rösler, C; Schlick, K; Greil, R; Sellner, J;

View this publication in the PUBMED database

T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
Zelle-Rieser, C; Thangavadivel, S; Biedermann, R; Brunner, A; Stoitzner, P; Willenbacher, E; Greil, R; Jöhrer, K;

View this publication in the PUBMED database

A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study
Leierer, G; Grabmeier-Pfistershammer, K; Steuer, A; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Rappold, M; Ledergerber, B; Zangerle, R

View this publication in the PUBMED database

Denosumab in the Treatment of Breast Cancer Patients with Bone Metastasis
Steger, G; Bartsch, R; Fridrik, MA; Gampenrieder, SP; Marth, C

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
Karthaus, M; Hofheinz, RD; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Oliner, KS; Boedigheimer, M; Twomey, B; Zhang, Y; Demonty, G; Köhne, CH;

View this publication in the PUBMED database

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M;

View this publication in the PUBMED database

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
Foukakis, T; von Minckwitz, G; Bengtsson, NO; Brandberg, Y; Wallberg, B; Fornander, T; Mlineritsch, B; Schmatloch, S; Singer, CF; Steger, G; Egle, D; Karlsson, E; Carlsson, L; Loibl, S; Untch, M; Hellström, M; Johansson, H; Anderson, H; Malmström, P; Gnant, M; Greil, R; Möbus, V; Bergh, J;

View this publication in the PUBMED database

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.
Steiner, M; Harrer, A; Himly, M;

View this publication in the PUBMED database

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M; Burk, AS; Franz, CM; Pace, G; Kastilan, T; Breuhahn, K; Hinterseer, E; Dierich, A; Bakiri, L; Wagner, EF; Ponta, H; Hartmann, TN; Tanaka, M; Orian-Rousseau, V;

View this publication in the PUBMED database

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer, K; Goergen, H; Müller, H; Thielen, I; Brillant, C; Kreissl, S; Halbsguth, TV; Meissner, J; Greil, R; Moosmann, P; Shonukan, O; Rueffer, JU; Flechtner, HH; Fuchs, M; Diehl, V; Engert, A; Borchmann, P;

View this publication in the PUBMED database

The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.
Steiner, M; Huber, S; Harrer, A; Himly, M;

View this publication in the PUBMED database

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M; Müller, A; Egle, A; Erlacher, M;

View this publication in the PUBMED database

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Fridrik, M; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A;

View this publication in the PUBMED database

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?
Benedetti, D; Tissino, E; Caldana, C; Dal Bo, M; Bomben, R; Marconi, D; Ganghammer, S; Zaja, F; Pozzato, G; Di Raimondo, F; Hartmann, TN; Del Poeta, G; VanMeter, A; Zucchetto, A; Espina, V; Liotta, L; Gattei, V;

View this publication in the PUBMED database

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler, G; Hackl, H; Gampenrieder, SP; Hamacher, F; Hufnagl, C; Hauser-Kronberger, C; Zehentmayr, F; Fastner, G; Sedlmayer, F; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Hanna, BS; McClanahan, F; Yazdanparast, H; Zaborsky, N; Kalter, V; Rößner, PM; Benner, A; Dürr, C; Egle, A; Gribben, JG; Lichter, P; Seiffert, M;

View this publication in the PUBMED database

A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
Cadamuro, J; Skocic, M; Meisl, B; Raggam, RB; Felder, TK; Prüller, F; Reinstadler, K; Wiedemann, H; Mrazek, C;

View this publication in the PUBMED database

Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction
Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Jung, C; Hoppe, UC; Lichtenauer, M

View this publication in the PUBMED database

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M;

View this publication in the PUBMED database

ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
Krenn, PW; Hofbauer, SW; Pucher, S; Hutterer, E; Hinterseer, E; Denk, U; Asslaber, D; Ganghammer, S; Sternberg, C; Neureiter, D; Aberger, F; Wickström, SA; Egle, A; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Suker, M; Beumer, BR; Sadot, E; Marthey, L; Faris, JE; Mellon, EA; El-Rayes, BF; Wang-Gillam, A; Lacy, J; Hosein, PJ; Moorcraft, SY; Conroy, T; Hohla, F; Allen, P; Taieb, J; Hong, TS; Shridhar, R; Chau, I; van Eijck, CH; Koerkamp, BG

View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B; Goergen, H; Behringer, K; Bröckelmann, PJ; Hitz, F; Kerkhoff, A; Greil, R; von Tresckow, B; Eichenauer, DA; Bürkle, C; Borchmann, S; Fuchs, M; Diehl, V; Engert, A; Borchmann, P;

View this publication in the PUBMED database

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, KA; Liptrot, S; O"Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P;

View this publication in the PUBMED database

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z;

View this publication in the PUBMED database

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer, SW; Krenn, PW; Piñόn Hofbauer, J; Pucher, S; Asslaber, D; Egle, A; Hartmann, TN; Greil, R;

View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M;

View this publication in the PUBMED database

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA; Jaeger, U; Petzer, A; Willenbacher, W; Keil, F; Lang, A; Andel, J; Burgstaller, S; Krieger, O; Oberaigner, W; Sihorsch, K; Greil, R;

View this publication in the PUBMED database

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
Ganghammer, S; Gutjahr, J; Hutterer, E; Krenn, PW; Pucher, S; Zelle-Rieser, C; Jöhrer, K; Wijtmans, M; Leurs, R; Smit, MJ; Gattei, V; Greil, R; Hartmann, TN;

View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Sill, H; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Zebisch, A; Pichler, A; Pfeilstöcker, M; Autzinger, EM; Lang, A; Geissler, K; Voskova, D; Geissler, D; Sperr, WR; Hojas, S; Rogulj, IM; Andel, J; Greil, R;

View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T; Melchardt, T; Weiss, L; Hufnagl, C; Greil, R; Egle, A;

View this publication in the PUBMED database

Adjuvant medical treatment for breast cancer in elderly and old women
Westphal, T; Rinnerthaler, G; Mlineritsch, B

View this publication in the PUBMED database

CDK4/6 inhibition in luminal breast cancer.
Gampenrieder, SP; Rinnerthaler, G; Greil, R;

View this publication in the PUBMED database

Immune checkpoint blockade in ovarian cancer.
Weiss, L; Huemer, F; Mlineritsch, B; Greil, R;

View this publication in the PUBMED database

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer, L; Valent, P; Greil, R;

View this publication in the PUBMED database

3. Poast-SABCS 2015: Tumorinfiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, SP

Impact of Red Blood Cell Alloimmunization in Patients with MDS, AML and CMML
Leisch M, Weiß L, Lindlbauer N, Rohde E, Greil R, Grabmer C, Pleyer L

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Kollagenosen
Psenak, O;

Tumor-infiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, SP;

CDK4/6: Intranukleäre vs. zytoplasmische Inhibition
Gampenrieder, SP;

CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Koller, U

R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting
Petzer, A; Herndlhofer, S; Weltermann, A; Sliwa, T; Schmidt, S; Greil, R; Molfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR

Much less treatment modification with recently approved drugs: the Austrian HIV Cohort Study
Rappold, M; Rieger, A; Schmied, B; Sarcletti, M; Geit, M; Haas, B; Taylor, N; Kanatschnig, M; Leierer, G; Ledergerber, B; Zangerle, R

Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB
Reichl, VM; Kienzl, M; Stocklinger, A; Tockner, B; Reichelt, J; Gruber, C; Pinon-Hofbauer, J

Tissue microRNAs predicting the pattern of breast cancer metastases
Gampenrieder, SP; Hackl, H; Rinnerthaler, G; Steiner, M; Hufnagl, C; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

Tumor response as important parameter during first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab plus FOLFIRI
Karthaus, M; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Zhang, Y; Demonty, G; Kohne, CH

The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial
Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF

Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M

DNA methylation patterns correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
Gampenrieder, SP; Rinnerthaler, G; Weinhausel, A; Pulverer, W; Hugnagl, C; Hackl, H; Romeder, F; Fuentes, CM; Hauser-Kronberger, C; Mlineritsch, B; Greil, R

A CXCR4 inhibitor and Btk inhibitor ONO/GS-4059 are synergistic and result in loss of CLL cell migratory ability and survival
Lewis, T; Proctor, VK; Brennan, P; Pratt, G; Hartmann, TN; Buggins, AGS; Yoshizawa, T; Fegan, C; Pepper, C; Walsby, EJ

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R

Blocking CD62L inhibits CLL cell interaction with vascular endothelium; an effect that is augmented by ibrutinib
Shere, C; Hartmann, TN; Pratt, G; Fegan, C; Pepper, C; Walsby, EJ

CXCL12 ANTAGONISM BY THE L-RNA APTAMER OLAPTESED PEGOL IS EFFECTIVE AS A MOBILIZING AND THERAPEUTIC AGENT IN A MURINE CHRONIC LYMPHOCYTIC LEUKEMIA MODEL
Hinterseer, E; Hutterer, E; Krenn, PW; Reinthaler, P; Hopner, J; Hopfinger, M; Eulberg, D; Maasch, C; Kruschinski, A; Vater, A; Egle, A; Greil, R; Hartmann, TN

CD49D EXPRESSION IMPACTS ON THE IBRUTINIB-INDUCED LYMPHOCYTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A ROLE OF BCR-MEDIATED INSIDE-OUT VLA-4 INTEGRIN ACTIVATION
Tissino, E; Caldana, C; Benedetti, D; Herman, SE; ten Hacken, E; Rossi, FM; Dal Bo, M; Bulian, P; Bomben, R; Zaja, F; Chiarenza, A; Sklar, LA; Hartmann, TN; Chigaev, A; Burger, JA; Del Poeta, G; Wiestner, A; Gattei, V; Zucchetto, A

OUTCOME OF PATIENTS WITH REFRACTORY OR RELAPSED AML WITH IDH1 AND IDH2 MUTATIONS AFTER CONVENTIONAL SALVAGE THERAPY: A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
Paschka, P; Schlenk, R; Weber, D; Horst, HA; Ringhoffer, M; Khone, CH; Held, G; Kundgen, A; Gotze, K; Brossart, P; Greil, R; Lubbert, M; Wattad, M; Rummel, MJ; Heuser, M; Gaidzik, VI; Teleanu, V; Thol, F; Gohring, G; Ganser, A; Dohner, K; Dohner, H

Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U

Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma
Kienzl, M; Leb-Reichl, V; Stoecklinger, A; Tockner, B; Gratz, IK; Bauer, JW; Reichelt, J; Gruber, C; Hofbauer, JP

CRISPR/Cas9-mediated gene repair in the COL7A1 gene
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Reichelt, J; Koller, U

Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP

Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
Steger, G; Petru, E; Haslbauer, F; Egle, D; Galid, A; Sliwa, T; Lang, A; Kuhr, T; Petzer, A; Ruckser, R; Mlineritsch, B; Greil, R; Seifert, M; Singer, C; Andel, J; Kwasny, W; Marth, C; Pichler, P; Tinchon, C; Bartsch, R

An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M

Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Mlineritsch, B; Greil, R

Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa
Welponer, T; Hofbauer, JP; Gruber, C; Kienzl, M; Aminzadeh-Gohari, S; Feichtinger, R; Lang, R; Bauer, JW; Kofler, B; Reichelt, J

Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction
Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Wuppinger, T; Moesenlechner, T; Ausserwinkler, M; Jung, C; Hoppe, UC; Lichtenauer, M

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
Lancet Haematol. 2016, 3(7): e317-e329.
View this publication in the PUBMED database

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.
Steiner, M, Harrer, A, Himly, M.
Front Pharmacol. 2016, 7: 171.
View this publication in the PUBMED database

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15): 2779-2810.
View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016, xx:.
View this publication in the PUBMED database

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
Front Neurol. 2016, 7:196.
View this publication in the PUBMED database

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
Ann Hematol. 2016, 95(12):197-1988.
View this publication in the PUBMED database

Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2016.
View this publication in the PUBMED database

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Br J Cancer. 2016, xx:.
View this publication in the PUBMED database

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
Cell Death Dis. 2016, 7(11):e2461.
View this publication in the PUBMED database

CD44: More than a mere stem cell marker.
Morath, I, Hartmann, TN, Orian-Rousseau, V.
Int J Biochem Cell Biol. 2016.
View this publication in the PUBMED database

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Rachar, V, Czejka, M, Kitzmueller, M, Buchner, P, Lichtneckert, M, Greil, R, Geiler, H, Dittrich, C.
ANTICANCER RES. 2016, 36(9): 4715-4723.
View this publication in the PUBMED database

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide?+?dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X, Terpos, E, Sanz, RG, Cooney, J, O"Gorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z.
AM J HEMATOL. 2016, 91(8): 806-811.
View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
PLOS ONE. 2016, 11(2): e0149275.
View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstöcker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
J HEMATOL ONCOL. 2016, 9: 39.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
J Clin Oncol. 2016, 34(20): 2433-2434.
View this publication in the PUBMED database

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis -Masters of Survival and Clonality?.
Pleyer, L, Valent, P, Greil, R.
INT J MOL SCI. 2016, 17(7): 1009.
View this publication in the PUBMED database

Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.
Pikija, S, Pilz, G, Gschwandtner, G, Rösler, C, Schlick, K, Greil, R, Sellner, J.
Front Neurol. 2016, 7:196.

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
Haerzschel, A, Catusse, J, Hutterer, E, Paunovic, M, Zirlik, K, Eibel, H, Krenn, PW, Hartmann, TN, Burger, M.
Ann Hematol. 2016, 95(12):197-1988.

Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H.
J Acquir Immune Defic Syndr. 2016.

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F, Dejaco, M, Grabmer, C, Melchardt, T, Neureiter, D, Mayer, G, Egle, A, Greil, R, Weiss, L.
Wien Klin Wochenschr. 2016.

Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.
Shatirishvili, M, Burk, AS, Franz, CM, Pace, G, Kastilan, T, Breuhahn, K, Hinterseer, E, Dierich, A, Bakiri, L, Wagner, EF, Ponta, H, Hartmann, TN, Tanaka, M, Orian-Rousseau, V.
Cell Death Dis. 2016, 7(11):e2461.

CD44: More than a mere stem cell marker.
Morath, I, Hartmann, TN, Orian-Rousseau, V.
Int J Biochem Cell Biol. 2016.

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
Leukemia. 2016, 30(2): 513-517.

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.
Steiner, M, Harrer, A, Himly, M.
Front Pharmacol. 2016, 7:171.

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.
Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
Int J Mol Sci. 2016, 17(2).

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Greil, R, Obrtlíková, P, Smolej, L, Kozák, T, Steurer, M, Andel, J, Burgstaller, S, Mikušková, E, Gercheva, L, Nösslinger, T, Papajík, T, Ladická, M, Girschikofsky, M, Hrubiško, M, Jäger, U, Fridrik, M, Pecherstorfer, M, Králiková, E, Burcoveanu, C, Spasov, E, Petzer, A, Mihaylov, G, Raynov, J, Oexle, H, Zabernigg, A, Flochová, E, Palášthy, S, Stehlíková, O, Doubek, M, Altenhofer, P, Pleyer, L, Melchardt, T, Klingler, A, Mayer, J, Egle, A.
Lancet Haematol. 2016, 3(7):e317-e329.

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic HematopoiesisMasters of Survival and Clonality?.
Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
Oncotarget. 2016.

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15):2779-2810.

Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016.

Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa.
Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
Leuk Lymphoma. 2016, 57(10):2330-2341.

Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa.
Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
JAMA Oncol. 2016.

Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2016.

CRISPR/Cas9-mediated gene repair in the COL7A1 gene.
Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D, Klieser, E, Greil, R, Neumeister, P, Egle, A, Pichler, M.
Br J Cancer. 2016.

CDK4/6 inhibition in luminal breast cancer.
Gampenrieder, SP, Rinnerthaler, G, Greil, R.
MEMO-MAG EUR MED ONC. 2016, 9(2): 76-81.

Bcl-2 proteins in development, health, and disease of the hematopoietic system.
Kollek, M, MГјller, A, Egle, A, Erlacher, M.
FEBS J. 2016, 283(15):2779-2810.
View this publication in the PUBMED database

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer, L, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Machherndl-Spandl, S, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Geissler, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R.
J Hematol Oncol. 2016, 9:39.
View this publication in the PUBMED database

Immune checkpoint blockade in ovarian cancer.
Weiss, L, Huemer, F, Mlineritsch, B, Greil, R.
Memo. 2016, 9:82-84.
View this publication in the PUBMED database

Adjuvant medical treatment for breast cancer in elderly and old women.
Westphal, T, Rinnerthaler, G, Mlineritsch, B.
MEMO-MAG EUR MED ONC. 2016, 9(1): 17-19.

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky, N, Gassner, FJ, Asslaber, D, Reinthaler, P, Denk, U, Flenady, S, Hofbauer, JP, Danner, B, Rebhandl, S, Harrer, A, Geisberger, R, Greil, R, Egle, A.
Oncotarget. 2016.
View this publication in the PUBMED database

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Suker, M, Beumer, BR, Sadot, E, Marthey, L, Faris, JE, Mellon, EA, El-Rayes, BF, Wang-Gillam, A, Lacy, J, Hosein, PJ, Moorcraft, SY, Conroy, T, Hohla, F, Allen, P, Taieb, J, Hong, TS, Shridhar, R, Chau, I, van Eijck, CH, Koerkamp, BG.
Lancet Oncol. 2016, 17(6):801-810.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A,.
J Clin Oncol. 2016, 34(20):2433-2434.
View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
Blood. 2016, 127(18):2189-2192.
View this publication in the PUBMED database

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?.
Benedetti, D, Tissino, E, Caldana, C, Dal Bo, M, Bomben, R, Marconi, D, Ganghammer, S, Zaja, F, Pozzato, G, Di Raimondo, F, Hartmann, TN, Del Poeta, G, VanMeter, A, Zucchetto, A, Espina, V, Liotta, L, Gattei, V.
Leukemia. 2016, 30(2): 513-517.
View this publication in the PUBMED database

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T, Melchardt, T, Weiss, L, Hufnagl, C, Greil, R, Egle, A.
J Clin Oncol. 2016.
View this publication in the PUBMED database

Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
Himly, M, Nandy, A, Kahlert, H, Thilker, M, Steiner, M, Briza, P, Neubauer, A, Klysner, S, van Ree, R, Buchheit, KH, Vieths, S, Ferreira, F,f.
Allergy. 2016, 71(4):49-504.
View this publication in the PUBMED database

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
Hanna, BS, McClanahan, F, Yazdanparast, H, Zaborsky, N, Kalter, V, Rößner, PM, Benner, A, Dürr, C, Egle, A, Gribben, JG, Lichter, P, Seiffert, M.
Leukemia. 2016, 30(3): 570-579.
View this publication in the PUBMED database

A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
Cadamuro, J, Skocic, M, Meisl, B, Raggam, RB, Felder, TK, PrГјller, F, Reinstadler, K, Wiedemann, H, Mrazek, C.
Clin Chem Lab Med. 2016, 54(7):e203-e206.
View this publication in the PUBMED database

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, KT, Melchardt, T, Wenzl, K, Schlick, K, Deutsch, A, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Tränkenschuh, W, Greil, R, Neumeister, P, Egle, A, Pichler, M.
J Clin Pathol. 2016, 69(4):326-330.
View this publication in the PUBMED database

ILK Induction in Lymphoid Organs by a TNFО±-NF-ОєB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
Krenn, PW, Hofbauer, SW, Pucher, S, Hutterer, E, Hinterseer, E, Denk, U, Asslaber, D, Ganghammer, S, Sternberg, C, Neureiter, D, Aberger, F, Wickström, SA, Egle, A, Greil, R, Hartmann, TN.
Cancer Res. 2016, 76(8):2186-2196.
View this publication in the PUBMED database

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer, SW, Krenn, PW, PiГ±ПЊn Hofbauer, J, Pucher, S, Asslaber, D, Egle, A, Hartmann, TN, Greil, R.
Br J Haematol. 2016, 172(5): 815-819.
View this publication in the PUBMED database

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M, Hawranek, T, Schneider, M, Ferreira, F, Horejs-Hoeck, J, Harrer, A, Himly, M.
PLoS One. 2016, 11(2):e0149275.
View this publication in the PUBMED database

Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA, Jaeger, U, Petzer, A, Willenbacher, W, Keil, F, Lang, A, Andel, J, Burgstaller, S, Krieger, O, Oberaigner, W, Sihorsch, K, Greil, R.
Eur J Cancer. 2016, 58:112-121.
View this publication in the PUBMED database

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
Ganghammer, S, Gutjahr, J, Hutterer, E, Krenn, PW, Pucher, S, Zelle-Rieser, C, Jöhrer, K, Wijtmans, M, Leurs, R, Smit, MJ, Gattei, V, Greil, R, Hartmann, TN.
Haematologica. 2016, 101(3):e99-e102.
View this publication in the PUBMED database

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Rawstron, AC, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, KA, Liptrot, S, O"Brien, D, de Tute, RM, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, AP, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, JL, Stetler-Stevenson, M, Yuan, C, Broome, HE, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, CM, Emerson, R, Robins, HS, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, TJ, Wierda, WG, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P.
Leukemia. 2016, 30(4):929-936.
View this publication in the PUBMED database

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R.
Pharmacogenomics J. 2016.
View this publication in the PUBMED database

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T, Hufnagl, C, Weinstock, DM, Kopp, N, Neureiter, D, Tränkenschuh, W, Hackl, H, Weiss, L, Rinnerthaler, G, Hartmann, TN, Greil, R, Weigert, O, Egle, A.
Oncotarget. 2016.
View this publication in the PUBMED database

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.
Leuk Lymphoma. 2016, xx: -12.
View this publication in the PUBMED database

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A, Borchmann, P.
Blood. 2016, 127(18):2189-2192.
View this publication in the PUBMED database

DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige, V, Vincent, M, Alexandre, P, Tejpar, S, Landolfi, S, Le Malicot, K, Greil, R, Cuyle, PJ, Yilmaz, M, Faroux, R, Matzdorff, A, Salazar, R, Lepage, C, Taieb, J, Laurent-Puig, P.
JAMA Oncol. 2016, xx.
View this publication in the PUBMED database

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler, G, Hackl, H, Gampenrieder, SP, Hamacher, F, Hufnagl, C, Hauser-Kronberger, C, Zehentmayr, F, Fastner, G, Sedlmayer, F, Mlineritsch, B, Greil, R.
Int J Mol Sci. 2016, 17(2).
View this publication in the PUBMED database

Rheumatoide Arthritis
Psenak, O;

Differentialdiagnose der Gelenksentzündungen, Kollagenosen
Psenak, O;

Update HER2-Therapie: Ist weniger mehr? Ist es bereits Zeit für Deeskalation?
Gampenrieder, SP;

ABCSG 42 / PALLAS: Überblick über die Datenlage zu Palbociclib
Gampenrieder, SP;

Neue Therapieansätze beim fortgeschrittenen Mammakarzinom: Fokus auf den CDK4/6 Pathway
Gampenrieder, SP;

Musikhören bei Depression und Demenz: von der Hirnforschung zur klinischen Anwendung
Bernatzky, G; Grebosz-Haring, K; Wendtner, F; Kreutz, G;

Amphiregulin (AREG) expression and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
Kohne, CH; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Twomey, B; Oliner, KS; Boedigheimer, M; Terwey, JH; Karthaus, M

Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
Kohne, CH; Hofheinz, RD; Mineur, L; Letocha, H; Greil, R; Thaler, J; Twomey, B; Oliner, KS; Boedigheimer, M; Terwey, JH; Karthaus, M

Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial.
Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Radisic, VB; Bergh, JCS; Fitzal, F; Egle, D; Mlineritsch, B; Steger, GG; Talbot, S; Warner, DJ; Fesl, C; Singer, CF